tag:blogger.com,1999:blog-33457195251330435832024-03-26T11:06:11.496-07:00Ada RomaLa nostra associazione di volontariato è decisa a prendere ogni iniziativa per una più efficace cura medica e di prevenzione anzichè inutili pratiche burocratiche considerando la cronicità della malattia.
Il nostro progetto nasce dallo studio della <b>vita quotidiane di noi pazienti diabetici</b>.Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.comBlogger67125tag:blogger.com,1999:blog-3345719525133043583.post-21406070555933757562024-02-29T10:30:00.000-08:002024-02-29T10:42:12.433-08:00PRIMO SOCCORSO PER IL PAZIENTE DIABETICO<div class="separator" style="text-align: justify;"><h3 style="clear: left; float: left; margin-bottom: 1em; margin-left: 1em;"><span> </span><span> </span>In qualità di presidente dell'<span style="color: #0b5394;">ADA ROMA - ASSOCIAZIONE DIABETICI - ODV</span> voglio ringraziare il <span style="color: red;">Dottor RICCARDO SONNINO </span>per quanto esposto nel sottostante documento e che tutti i parenti e persone che convivono con pazienti diabetici dovrebbero conoscere. <span> </span><span> </span><span> </span><span> </span><span> <span> </span><span> </span><span> </span><span> </span><span> </span> </span>Venanzo Paganelli<br /></h3></div><p><br /></p><p><!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]--><!--[if gte mso 9]><xml>
<o:OfficeDocumentSettings>
<o:AllowPNG/>
</o:OfficeDocumentSettings>
</xml><![endif]--><!--[if gte mso 9]><xml>
<w:WordDocument>
<w:View>Normal</w:View>
<w:Zoom>0</w:Zoom>
<w:TrackMoves>false</w:TrackMoves>
<w:TrackFormatting/>
<w:HyphenationZone>14</w:HyphenationZone>
<w:PunctuationKerning/>
<w:ValidateAgainstSchemas/>
<w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
<w:IgnoreMixedContent>false</w:IgnoreMixedContent>
<w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
<w:DoNotPromoteQF/>
<w:LidThemeOther>IT</w:LidThemeOther>
<w:LidThemeAsian>X-NONE</w:LidThemeAsian>
<w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
<w:Compatibility>
<w:BreakWrappedTables/>
<w:SnapToGridInCell/>
<w:WrapTextWithPunct/>
<w:UseAsianBreakRules/>
<w:DontGrowAutofit/>
<w:SplitPgBreakAndParaMark/>
<w:EnableOpenTypeKerning/>
<w:DontFlipMirrorIndents/>
<w:OverrideTableStyleHps/>
</w:Compatibility>
<m:mathPr>
<m:mathFont m:val="Cambria Math"/>
<m:brkBin m:val="before"/>
<m:brkBinSub m:val="--"/>
<m:smallFrac m:val="off"/>
<m:dispDef/>
<m:lMargin m:val="0"/>
<m:rMargin m:val="0"/>
<m:defJc m:val="centerGroup"/>
<m:wrapIndent m:val="1440"/>
<m:intLim m:val="subSup"/>
<m:naryLim m:val="undOvr"/>
</m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
<w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false"
DefSemiHidden="false" DefQFormat="false" DefPriority="99"
LatentStyleCount="376">
<w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"/>
<w:LsdException Locked="false" Priority="9" SemiHidden="true"
UnhideWhenUsed="true" QFormat="true" Name="heading 2"/>
<w:LsdException Locked="false" Priority="9" SemiHidden="true"
UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>
<w:LsdException Locked="false" Priority="9" SemiHidden="true"
UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>
<w:LsdException Locked="false" Priority="9" SemiHidden="true"
UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>
<w:LsdException Locked="false" Priority="9" SemiHidden="true"
UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>
<w:LsdException Locked="false" Priority="9" SemiHidden="true"
UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>
<w:LsdException Locked="false" Priority="9" SemiHidden="true"
UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>
<w:LsdException Locked="false" Priority="9" SemiHidden="true"
UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="index 1"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="index 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="index 3"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="index 4"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="index 5"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="index 6"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="index 7"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="index 8"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="index 9"/>
<w:LsdException Locked="false" Priority="39" SemiHidden="true"
UnhideWhenUsed="true" Name="toc 1"/>
<w:LsdException Locked="false" Priority="39" SemiHidden="true"
UnhideWhenUsed="true" Name="toc 2"/>
<w:LsdException Locked="false" Priority="39" SemiHidden="true"
UnhideWhenUsed="true" Name="toc 3"/>
<w:LsdException Locked="false" Priority="39" SemiHidden="true"
UnhideWhenUsed="true" Name="toc 4"/>
<w:LsdException Locked="false" Priority="39" SemiHidden="true"
UnhideWhenUsed="true" Name="toc 5"/>
<w:LsdException Locked="false" Priority="39" SemiHidden="true"
UnhideWhenUsed="true" Name="toc 6"/>
<w:LsdException Locked="false" Priority="39" SemiHidden="true"
UnhideWhenUsed="true" Name="toc 7"/>
<w:LsdException Locked="false" Priority="39" SemiHidden="true"
UnhideWhenUsed="true" Name="toc 8"/>
<w:LsdException Locked="false" Priority="39" SemiHidden="true"
UnhideWhenUsed="true" Name="toc 9"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Normal Indent"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="footnote text"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="annotation text"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="header"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="footer"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="index heading"/>
<w:LsdException Locked="false" Priority="35" SemiHidden="true"
UnhideWhenUsed="true" QFormat="true" Name="caption"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="table of figures"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="envelope address"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="envelope return"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="footnote reference"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="annotation reference"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="line number"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="page number"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="endnote reference"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="endnote text"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="table of authorities"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="macro"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="toa heading"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List Bullet"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List Number"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List 3"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List 4"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List 5"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List Bullet 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List Bullet 3"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List Bullet 4"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List Bullet 5"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List Number 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List Number 3"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List Number 4"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List Number 5"/>
<w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Closing"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Signature"/>
<w:LsdException Locked="false" Priority="1" SemiHidden="true"
UnhideWhenUsed="true" Name="Default Paragraph Font"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Body Text"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Body Text Indent"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List Continue"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List Continue 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List Continue 3"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List Continue 4"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="List Continue 5"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Message Header"/>
<w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Salutation"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Date"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Body Text First Indent"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Body Text First Indent 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Note Heading"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Body Text 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Body Text 3"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Body Text Indent 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Body Text Indent 3"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Block Text"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Hyperlink"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="FollowedHyperlink"/>
<w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"/>
<w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Document Map"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Plain Text"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="E-mail Signature"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="HTML Top of Form"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="HTML Bottom of Form"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Normal (Web)"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="HTML Acronym"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="HTML Address"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="HTML Cite"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="HTML Code"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="HTML Definition"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="HTML Keyboard"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="HTML Preformatted"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="HTML Sample"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="HTML Typewriter"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="HTML Variable"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Normal Table"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="annotation subject"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="No List"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Outline List 1"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Outline List 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Outline List 3"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Simple 1"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Simple 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Simple 3"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Classic 1"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Classic 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Classic 3"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Classic 4"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Colorful 1"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Colorful 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Colorful 3"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Columns 1"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Columns 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Columns 3"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Columns 4"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Columns 5"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Grid 1"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Grid 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Grid 3"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Grid 4"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Grid 5"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Grid 6"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Grid 7"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Grid 8"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table List 1"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table List 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table List 3"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table List 4"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table List 5"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table List 6"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table List 7"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table List 8"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table 3D effects 1"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table 3D effects 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table 3D effects 3"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Contemporary"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Elegant"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Professional"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Subtle 1"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Subtle 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Web 1"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Web 2"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Web 3"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Balloon Text"/>
<w:LsdException Locked="false" Priority="39" Name="Table Grid"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Table Theme"/>
<w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"/>
<w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"/>
<w:LsdException Locked="false" Priority="60" Name="Light Shading"/>
<w:LsdException Locked="false" Priority="61" Name="Light List"/>
<w:LsdException Locked="false" Priority="62" Name="Light Grid"/>
<w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"/>
<w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"/>
<w:LsdException Locked="false" Priority="65" Name="Medium List 1"/>
<w:LsdException Locked="false" Priority="66" Name="Medium List 2"/>
<w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"/>
<w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"/>
<w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"/>
<w:LsdException Locked="false" Priority="70" Name="Dark List"/>
<w:LsdException Locked="false" Priority="71" Name="Colorful Shading"/>
<w:LsdException Locked="false" Priority="72" Name="Colorful List"/>
<w:LsdException Locked="false" Priority="73" Name="Colorful Grid"/>
<w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"/>
<w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"/>
<w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"/>
<w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"/>
<w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"/>
<w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"/>
<w:LsdException Locked="false" SemiHidden="true" Name="Revision"/>
<w:LsdException Locked="false" Priority="34" QFormat="true"
Name="List Paragraph"/>
<w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"/>
<w:LsdException Locked="false" Priority="30" QFormat="true"
Name="Intense Quote"/>
<w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"/>
<w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"/>
<w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"/>
<w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"/>
<w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"/>
<w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"/>
<w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"/>
<w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"/>
<w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"/>
<w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"/>
<w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"/>
<w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"/>
<w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"/>
<w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"/>
<w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"/>
<w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"/>
<w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"/>
<w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"/>
<w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"/>
<w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"/>
<w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"/>
<w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"/>
<w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"/>
<w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"/>
<w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"/>
<w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"/>
<w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"/>
<w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"/>
<w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"/>
<w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"/>
<w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"/>
<w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"/>
<w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"/>
<w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"/>
<w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"/>
<w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"/>
<w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"/>
<w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"/>
<w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"/>
<w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"/>
<w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"/>
<w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"/>
<w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"/>
<w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"/>
<w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"/>
<w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"/>
<w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"/>
<w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"/>
<w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"/>
<w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"/>
<w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"/>
<w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"/>
<w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"/>
<w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"/>
<w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"/>
<w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"/>
<w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"/>
<w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"/>
<w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"/>
<w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"/>
<w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"/>
<w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"/>
<w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"/>
<w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"/>
<w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"/>
<w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"/>
<w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"/>
<w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"/>
<w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"/>
<w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"/>
<w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"/>
<w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"/>
<w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"/>
<w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"/>
<w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"/>
<w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"/>
<w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"/>
<w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"/>
<w:LsdException Locked="false" Priority="19" QFormat="true"
Name="Subtle Emphasis"/>
<w:LsdException Locked="false" Priority="21" QFormat="true"
Name="Intense Emphasis"/>
<w:LsdException Locked="false" Priority="31" QFormat="true"
Name="Subtle Reference"/>
<w:LsdException Locked="false" Priority="32" QFormat="true"
Name="Intense Reference"/>
<w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"/>
<w:LsdException Locked="false" Priority="37" SemiHidden="true"
UnhideWhenUsed="true" Name="Bibliography"/>
<w:LsdException Locked="false" Priority="39" SemiHidden="true"
UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>
<w:LsdException Locked="false" Priority="41" Name="Plain Table 1"/>
<w:LsdException Locked="false" Priority="42" Name="Plain Table 2"/>
<w:LsdException Locked="false" Priority="43" Name="Plain Table 3"/>
<w:LsdException Locked="false" Priority="44" Name="Plain Table 4"/>
<w:LsdException Locked="false" Priority="45" Name="Plain Table 5"/>
<w:LsdException Locked="false" Priority="40" Name="Grid Table Light"/>
<w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"/>
<w:LsdException Locked="false" Priority="47" Name="Grid Table 2"/>
<w:LsdException Locked="false" Priority="48" Name="Grid Table 3"/>
<w:LsdException Locked="false" Priority="49" Name="Grid Table 4"/>
<w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"/>
<w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"/>
<w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"/>
<w:LsdException Locked="false" Priority="46"
Name="Grid Table 1 Light Accent 1"/>
<w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"/>
<w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"/>
<w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"/>
<w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"/>
<w:LsdException Locked="false" Priority="51"
Name="Grid Table 6 Colorful Accent 1"/>
<w:LsdException Locked="false" Priority="52"
Name="Grid Table 7 Colorful Accent 1"/>
<w:LsdException Locked="false" Priority="46"
Name="Grid Table 1 Light Accent 2"/>
<w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"/>
<w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"/>
<w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"/>
<w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"/>
<w:LsdException Locked="false" Priority="51"
Name="Grid Table 6 Colorful Accent 2"/>
<w:LsdException Locked="false" Priority="52"
Name="Grid Table 7 Colorful Accent 2"/>
<w:LsdException Locked="false" Priority="46"
Name="Grid Table 1 Light Accent 3"/>
<w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"/>
<w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"/>
<w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"/>
<w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"/>
<w:LsdException Locked="false" Priority="51"
Name="Grid Table 6 Colorful Accent 3"/>
<w:LsdException Locked="false" Priority="52"
Name="Grid Table 7 Colorful Accent 3"/>
<w:LsdException Locked="false" Priority="46"
Name="Grid Table 1 Light Accent 4"/>
<w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"/>
<w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"/>
<w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"/>
<w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"/>
<w:LsdException Locked="false" Priority="51"
Name="Grid Table 6 Colorful Accent 4"/>
<w:LsdException Locked="false" Priority="52"
Name="Grid Table 7 Colorful Accent 4"/>
<w:LsdException Locked="false" Priority="46"
Name="Grid Table 1 Light Accent 5"/>
<w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"/>
<w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"/>
<w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"/>
<w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"/>
<w:LsdException Locked="false" Priority="51"
Name="Grid Table 6 Colorful Accent 5"/>
<w:LsdException Locked="false" Priority="52"
Name="Grid Table 7 Colorful Accent 5"/>
<w:LsdException Locked="false" Priority="46"
Name="Grid Table 1 Light Accent 6"/>
<w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"/>
<w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"/>
<w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"/>
<w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"/>
<w:LsdException Locked="false" Priority="51"
Name="Grid Table 6 Colorful Accent 6"/>
<w:LsdException Locked="false" Priority="52"
Name="Grid Table 7 Colorful Accent 6"/>
<w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"/>
<w:LsdException Locked="false" Priority="47" Name="List Table 2"/>
<w:LsdException Locked="false" Priority="48" Name="List Table 3"/>
<w:LsdException Locked="false" Priority="49" Name="List Table 4"/>
<w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"/>
<w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"/>
<w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"/>
<w:LsdException Locked="false" Priority="46"
Name="List Table 1 Light Accent 1"/>
<w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"/>
<w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"/>
<w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"/>
<w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"/>
<w:LsdException Locked="false" Priority="51"
Name="List Table 6 Colorful Accent 1"/>
<w:LsdException Locked="false" Priority="52"
Name="List Table 7 Colorful Accent 1"/>
<w:LsdException Locked="false" Priority="46"
Name="List Table 1 Light Accent 2"/>
<w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"/>
<w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"/>
<w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"/>
<w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"/>
<w:LsdException Locked="false" Priority="51"
Name="List Table 6 Colorful Accent 2"/>
<w:LsdException Locked="false" Priority="52"
Name="List Table 7 Colorful Accent 2"/>
<w:LsdException Locked="false" Priority="46"
Name="List Table 1 Light Accent 3"/>
<w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"/>
<w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"/>
<w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"/>
<w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"/>
<w:LsdException Locked="false" Priority="51"
Name="List Table 6 Colorful Accent 3"/>
<w:LsdException Locked="false" Priority="52"
Name="List Table 7 Colorful Accent 3"/>
<w:LsdException Locked="false" Priority="46"
Name="List Table 1 Light Accent 4"/>
<w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"/>
<w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"/>
<w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"/>
<w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"/>
<w:LsdException Locked="false" Priority="51"
Name="List Table 6 Colorful Accent 4"/>
<w:LsdException Locked="false" Priority="52"
Name="List Table 7 Colorful Accent 4"/>
<w:LsdException Locked="false" Priority="46"
Name="List Table 1 Light Accent 5"/>
<w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"/>
<w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"/>
<w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"/>
<w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"/>
<w:LsdException Locked="false" Priority="51"
Name="List Table 6 Colorful Accent 5"/>
<w:LsdException Locked="false" Priority="52"
Name="List Table 7 Colorful Accent 5"/>
<w:LsdException Locked="false" Priority="46"
Name="List Table 1 Light Accent 6"/>
<w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"/>
<w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"/>
<w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"/>
<w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"/>
<w:LsdException Locked="false" Priority="51"
Name="List Table 6 Colorful Accent 6"/>
<w:LsdException Locked="false" Priority="52"
Name="List Table 7 Colorful Accent 6"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Mention"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Smart Hyperlink"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Hashtag"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Unresolved Mention"/>
<w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
Name="Smart Link"/>
</w:LatentStyles>
</xml><![endif]--><!--[if gte mso 10]>
<style>
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:"Tabella normale";
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-parent:"";
mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
mso-para-margin:0cm;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:"Calibri",sans-serif;
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;
mso-font-kerning:1.0pt;
mso-ligatures:standardcontextual;
mso-fareast-language:EN-US;}
</style>
<![endif]-->
</p><h2 align="center" class="MsoNormal" style="text-align: center;"><b> </b></h2><h2 align="center" class="MsoNormal" style="text-align: center;"><span style="font-size: x-large;"><b>Il paziente diabetico
ed il primo soccorso</b></span></h2>
<p align="center" class="MsoNormal" style="text-align: center;"></p>
<p class="MsoNormal" style="text-align: justify;">Il controllo costante dei valori
glicemici è alla base della prevenzione del rischio della comparsa di sintomi
acuti correlati alla patologia. Nella mia lunga esperienza professionale legata
alla gestione delle emergenze sanitarie nel territorio laziale ( sistema 118)
ho sempre dato la massima attenzione ai protocolli di trattamento degli episodi
di ipo ed iperglicemia che migliorassero la prognosi del paziente cercando di
evitare complicazioni anche gravi in grado di mettere a repentaglio la stessa
sopravvivenza. </p>
<p class="MsoNormal" style="text-align: justify;">IPOGLICEMIA .</p>
<p class="MsoNormal" style="text-align: justify;">Nella presente esposizione farò
riferimento alle crisi ipoglicemiche sia nel paziente adulto che nei piccoli
pazienti in quanto i protocolli di intervento sono simili e si discostano solo
per i dosaggi dei farmaci da utilizzare e per le vie di somministrazione che
possono variare a seconda dei casi e delle capacità di intervento del
soccorritore. Nelle ipoglicemie “acute” così come in ogni altro tipo di
emergenza il primo fattore da prendere in considerazione è il fattore T (
tempo) , prima si interviene e più aumentano le possibilità di evitare
complicanze. Ma per intervenire in tempi brevi e correttamente è fondamentale
riconoscere i sintomi premonitori prima che si manifestino quelli più
compromettenti. </p>
<p class="MsoNormal" style="text-align: justify;">Solo per dovere di chiarezza
conviene ricordare che è proprio il paziente diabetico a correre il rischio di
andare in ipoglicemia ed è paradossale che chi ha in genere valori glicemici
elevati o comunque di base sopra la norma possa incappare in questo
inconveniente. Le cause le riconduco a semplici esempi che servono solo per
chiarire un quadro clinico : </p>
<p class="MsoNormal" style="text-align: justify;">a) un paziente diabetico si
somministra per errore una dose eccessiva di insulina o di antidiabetico orale</p>
<p class="MsoNormal" style="text-align: justify;">b) un paziente assume poche
calorie rispetto alla dose di farmaco previsto<span style="mso-spacerun: yes;">
</span></p>
<p class="MsoNormal" style="text-align: justify;">c) un paziente consuma più
calorie del previsto per fatica, febbre, stress e quant’altro ed altre
situazioni particolari alcune prevedibili altre meno. </p>
<p class="MsoNormal" style="text-align: justify;">d) farmacoterapia/ormonterapia</p>
<p class="MsoNormal" style="text-align: justify;">Quale sia la causa che l’ha
provocata il paziente può andare in deficit di zucchero presente nel sangue
rispetto alle sue esigenze ed accusare una serie di sintomi che possono essere
premonitori di una crisi ipoglicemica.<span style="mso-spacerun: yes;">
</span>Tutti i nostri organi hanno bisogno di glucosio , ma fra questi quelli
più esigenti sono il sistema nervoso e quello muscolare spesso connessi fra
loro. </p>
<p class="MsoNormal" style="text-align: justify;">E quali possono essere questi
sintomi ? </p>
<p class="MsoNormal" style="text-align: justify;">Li elenco in maniera sequenziale
senza tenere conto della loro frequenza che varia da caso a caso:</p>
<p class="MsoNormal" style="text-align: justify;"> </p>
<p class="MsoListParagraphCxSpFirst" style="mso-list: l0 level1 lfo1; text-align: justify; text-indent: -18pt;"><span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt "Times New Roman";">
</span></span></span>Cefalea</p>
<p class="MsoListParagraphCxSpMiddle" style="mso-list: l0 level1 lfo1; text-align: justify; text-indent: -18pt;"><span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt "Times New Roman";">
</span></span></span>Confusione mentale </p>
<p class="MsoListParagraphCxSpMiddle" style="mso-list: l0 level1 lfo1; text-align: justify; text-indent: -18pt;"><span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt "Times New Roman";">
</span></span></span>Sudorazione profusa</p>
<p class="MsoListParagraphCxSpMiddle" style="mso-list: l0 level1 lfo1; text-align: justify; text-indent: -18pt;"><span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt "Times New Roman";">
</span></span></span>Cardiopalmo ( tachicardia)</p>
<p class="MsoListParagraphCxSpMiddle" style="mso-list: l0 level1 lfo1; text-align: justify; text-indent: -18pt;"><span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt "Times New Roman";">
</span></span></span>Disturbi neurovegetativi quali nausea, vomito ,
eruttazioni etc</p>
<p class="MsoListParagraphCxSpMiddle" style="mso-list: l0 level1 lfo1; text-align: justify; text-indent: -18pt;"><span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt "Times New Roman";">
</span></span></span>Problemi alla vista </p>
<p class="MsoListParagraphCxSpMiddle" style="mso-list: l0 level1 lfo1; text-align: justify; text-indent: -18pt;"><span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt "Times New Roman";">
</span></span></span>Problemi di equilibrio </p>
<p class="MsoListParagraphCxSpMiddle" style="mso-list: l0 level1 lfo1; text-align: justify; text-indent: -18pt;"><span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt "Times New Roman";">
</span></span></span>Respiro affannoso </p>
<p class="MsoListParagraphCxSpMiddle" style="mso-list: l0 level1 lfo1; text-align: justify; text-indent: -18pt;"><span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt "Times New Roman";">
</span></span></span>Tremori</p>
<p class="MsoListParagraphCxSpMiddle" style="mso-list: l0 level1 lfo1; text-align: justify; text-indent: -18pt;"><span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt "Times New Roman";">
</span></span></span>Dolori muscolari -spasmi </p>
<p class="MsoListParagraphCxSpMiddle" style="mso-list: l0 level1 lfo1; text-align: justify; text-indent: -18pt;"><span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt "Times New Roman";">
</span></span></span>Convulsioni</p>
<p class="MsoListParagraphCxSpLast" style="mso-list: l0 level1 lfo1; text-align: justify; text-indent: -18pt;"><span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt "Times New Roman";">
</span></span></span>Fino a sintomi più gravi quali arresto cardiaco
e respiratorio</p>
<p class="MsoNormal" style="text-align: justify;"> </p>
<p class="MsoNormal" style="text-align: justify;">Può la crisi ipoglicemica
comportare un rischio per la sopravvivenza?</p>
<p class="MsoNormal" style="text-align: justify;">Si può prevenire una crisi di
questo tipo?</p>
<p class="MsoNormal" style="text-align: justify;"> </p>
<p class="MsoNormal" style="text-align: justify;">A queste domande direi certamente
si , ma non sarà il sistema 118 nel suo complesso a porre un rimedio così
tempestivo quali le circostanze richiederebbero. Cerco di essere più chiaro
possibile. Dal momento che una crisi ipoglicemca si manifesta al momento nel
quale è presumibile che arrivi un’ambulanza (se correttamente attivata) passano
sempre e comunque troppi minuti. Non c’è sistema di emergenza che sia in grado
di prendersi carico di un paziente in crisi ipoglicemica e quindi sintomatico
nei tempi attesi. Esistono due possibilità e sono le seguenti: a) il paziente
ha dei sintomi premonitori (quelli descritti in precedenza) e pone rimedio alla
ipoglicemia da solo, assumendo zuccheri a pronto effetto b) il paziente non ha
il tempo necessario per provvedere e chiedere aiuto e quindi deve affidarsi
all’intervento dei presenti. In questo caso sono loro a dover riconoscere i
sintomi ed a saperli interpretare quali secondari ad una ipoglicemia.</p>
<p class="MsoNormal" style="text-align: justify;">Come capirete non è un compito
semplicissimo ricondurre dei sintomi seppur evidenti ad una crisi ipoglicemici.
I quadri clinici possibili sono compatibili con una serie di patologie e quindi
non tipici della caduta dei valori glicemici. Proprio per questo motivo , nel
dubbio, senza doversi addentrare troppo nella clinica e dover a tutti costi
porre una diagnosi possibile, consiglio di porsi sempre il dubbio : sarà una
ipoglicemia?? E di conseguenza intervenire . Come?.</p>
<p class="MsoNormal" style="text-align: justify;">Nel caso di perdita di coscienza
bisogna lasciare a terra il paziente , alzargli le gambe , tirare leggermente
su la testa , proteggerlo dalle intemperie e chiamare i soccorsi ( 112/118)
e……somministrare zucchero ( una bustina tanto per cominciare)). Chiarisco che
lo zucchero non deve essere somministrato sciolto in acqua perché a paziente
incosciente l’acqua potrebbe imboccare le vie aeree<span style="mso-spacerun: yes;"> </span>e soffocarlo. Solo se il paziente può
deglutire si può provare a somministrare acqua e zucchero o bevande zuccherate
ma sempre con cautela ed interrompere la somministrazione appena compare la
tosse. A paziente non in grado di deglutire lo zucchero va posizionato
all’interno delle guance nello spazio <b><i>virtuale</i></b> fra denti e
interno guancia , detto vestibolo<span style="mso-spacerun: yes;"> </span><span style="mso-spacerun: yes;"> </span>, aiutandoci con le nostre dita per farci
spazio nella bocca del paziente . Vedi foto</p>
<p class="MsoNormal" style="text-align: justify;"> <img alt="" src="data:image/png;base64,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" /></p><p class="MsoNormal" style="text-align: justify;"></p>
<p class="MsoNormal" style="text-align: justify;">Se la terapia ha dato segni di
efficacia ed il paziente dopo alcuni secondi darà segni di ripresa possiamo
ripetere il trattamento e solo quando sarà in grado di deglutire potremmo
somministrargli liquidi zuccherati. Nel frattempo i soccorsi qualificati
saranno arrivati e ci penseranno loro. Mai svuotare lo zucchero sulla base
della lingua perché può aggrumarsi con la saliva e formare un vero e proprio
tappo che impedirà la respirazione. </p>
<p class="MsoNormal" style="text-align: justify;">Nel<span style="mso-spacerun: yes;"> </span>bambino il quadro clinico è sovrapponibile a
quello descritto per l’adulto. E’ possibile che siano maggiormente presenti
sintomi quali sonnolenza, sbadigli accentuati, tremori , sudorazione ma per il
resto non si segnalano particolari differenze. Anche in questo caso la
tempestività ( fattore T) è essenziale. Prima si interviene e minori saranno i
danni. Ovviamente il bambino ha bisogno di chi è presente per risolvere i suoi
problemi e non potrà farlo certamente da solo. I provvedimenti da adottare sono
gli stessi descritti per l’adulto ovverosia , intercettare i sintomi e passare
alla somministrazione di zucchero per via orale con le stesse modalità sempre
valutando la presenza o meno della deglutizione. <i><u>La somministrazione di
zucchero non comporterà mai<span style="mso-spacerun: yes;"> </span>alcun tipo
di danno collaterale né provocherà mai un coma iperglicemico…..chiaro??. </u></i>Al
contrario evitare la somministrazione di zucchero in un coma ipoglicemico potrà
essere fatale per il paziente.</p>
<p class="MsoNormal" style="text-align: justify;"> </p>
<p class="MsoNormal" style="text-align: justify;">IPERGLICEMIA /COMA IPERGLICEMICO</p>
<p class="MsoNormal" style="text-align: justify;">Dedico poche righe a questa
eventualità perché nella mia esperienza di rianimatore i casi di coma
iperglicemico si contano sulle dita di una mano . Per arrivare ad un coma
iperglicemico ci vuole molto tempo ( giorni-settimane o più ancora). Durante
tutto questo tempo il paziente ha trascurato di misurarsi la glicemia , ha
bevuto litri e litri di acqua al giorno ( 5/6/ o più) ed ha urinato decine di
volte al giorno. In sintesi si è molto, ma molto trascurato. I casi che mi
vengono alla mente e/o descritti in letteratura riguardano spesso pazienti
single, trascurati e in stato di pseudo abbandono. C’è quasi sempre un problema
di tipo sociale dietro a questi quadri , ripeto assai rari. I sintomi sono
legati ad uno sato confusionale, spesso di disorientamento fino ad arrivare a
comportamenti “ strampalati” e poi ricordo la sete incontenibile e
paradossalmente una stato di disidratazione e una diuresi decisamente fuori
controllo. Insomma per arrivare ad un coma iperglicemico ci vuole molto tempo e
durante questo tempo non c’è stato alcun tipo di controllo glicemico. Il coma
iperglicemico non avverrà mai nell’arco di pochi istanti ma sarà sempre
preceduto da quadri clinico/sintomatici molto evidenti che solo in caso di
abbandono e trascuratezza non potranno essere intercettati. Solo per dovere di
informazione vi dirò che il trattamento di un coma iperglicemico è assai
complesso e tipico di ambiente rianimatorio e non sarà un dosaggio di insulina
a risolverlo. </p>
<p class="MsoNormal" style="text-align: justify;">Concludo dicendo che per i
soccorritori siano essi laici o sanitari sarebbe fondamentale sapere se il
paziente/vittima è affetto o meno da patologie. Purtroppo davanti ad una persona
in estrema difficoltà o la stessa è in grado di fornirti elementi utili per un
trattamento d’urgenza oppure la prognosi si complica assai. Su questo specifico
argomento se vi farà piacere potrò essere più dettagliato in seguito. Grazie
per l’attenzione</p>
<p class="MsoNormal" style="text-align: justify;"> </p>
<p class="MsoNormal" style="text-align: justify;">Dott.Riccardo Sonnino</p>
<p class="MsoNormal" style="text-align: justify;">anestesista -rianimatore</p>
<p class="MsoNormal" style="text-align: justify;">già direttore Ares 118</p>
Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-50435612902105721802024-02-19T07:32:00.000-08:002024-02-19T07:32:12.324-08:00<p> </p><h2 class="contentheading">
<a class="contentpagetitle" href="https://www.comirap.it/solidarieta-ed-assistenza/1821-il-convegno-a-palazzo-baleani-a-roma-del-17-febbraio-2024-sul-tema-il-diabete-mellito-la-donna-al-centro-a-cura-di-alberto-bordi-responsabile-comunicazione-ada-roma.html">
Il Convegno a palazzo Baleani in Roma del 17 febbraio 2024 sul tema
“Il diabete mellito: la donna al centro” * (A cura di Alberto Bordi,
responsabile comunicazione ADA ROMA) </a>
</h2>
<div class="article-tools">
<div class="article-meta">
<span class="createdate">
Lunedì 19 Febbraio 2024 12:58 </span>
</div>
<div class="buttonheading">
<span>
<a href="https://www.comirap.it/component/mailto/?tmpl=component&link=570c62329a8a31cdf2f3193224ce1960411eb2f9" title="E-mail"><img alt="E-mail" src="https://www.comirap.it/templates/ja_purity/images/emailButton.png" /></a> </span>
<span>
<a href="https://www.comirap.it/solidarieta-ed-assistenza/1821-il-convegno-a-palazzo-baleani-a-roma-del-17-febbraio-2024-sul-tema-il-diabete-mellito-la-donna-al-centro-a-cura-di-alberto-bordi-responsabile-comunicazione-ada-roma.html?tmpl=component&print=1&layout=default&page=" rel="nofollow" title="Stampa"><img alt="Stampa" src="https://www.comirap.it/templates/ja_purity/images/printButton.png" /></a> </span>
<span>
<a href="https://www.comirap.it/solidarieta-ed-assistenza/1821-il-convegno-a-palazzo-baleani-a-roma-del-17-febbraio-2024-sul-tema-il-diabete-mellito-la-donna-al-centro-a-cura-di-alberto-bordi-responsabile-comunicazione-ada-roma.pdf" rel="nofollow" title="PDF"><img alt="PDF" src="https://www.comirap.it/templates/ja_purity/images/pdf_button.png" /></a> </span>
</div>
</div>
<div class="article-content">
<p><img border="0" src="https://www.comirap.it/images/stories/ada roma.jpg" style="float: left; margin: 5px;" width="150" /></p>
<p> </p>
<p> </p>
<p>Con l’aumento dell’età le donne presentano un maggior rischio di
sviluppare diabete, che può avere un impatto significativo sulla loro
salute, aumentando il rischio di complicanze sia classiche
(cardiovascolari, oculistiche, neurologiche) sia di più recente
individuazione (osteoporosi, demenza…)</p>
<p> </p>
<p>In un incontro con marcato carattere divulgativo, destinato quindi
anche alla grande platea degli associati alle organizzazioni che si
occupano di fornire assistenza alle persone affette da diabete, sono
emerse informazioni e valutazioni di grande interesse. L’incremento dei
casi di diabete mellito riguarda principalmente la patologia di tipo 2
(circa 90%) e solo per il 7/8% il diabete di tipo 1 (malattia
autoimmune), che però risulta prevalente nella fascia di bambini ed
adolescenti. Un dato è incontrovertibile, il diabete aumenta con l’età, e
se vivessimo fino a 200 anni riguarderebbe il 90% della popolazione,
perché con il passare del tempo diminuisce la secrezione dell’insulina
nell’organismo. I casi di diabete riguardano prevalentemente gli uomini,
ma la casistica si ribalta quando si prendono in considerazione le
donne dopo la menopausa, fattore che fa diminuire in modo rilevante la
protezione garantita dagli estrogeni.</p>
<p>Significativo è lo stile di vita, anche nella fase precedente alla
insorgenza di una vera e propria patologia diabetica. Di grande evidenza
il raffronto, posto all’attenzione della platea, tra due sorelle con
mestieri e stili di vita differenti, caratteristiche che riverberano sui
valori del sangue (in particolare sull’emoglobina glicata) utili a
prevedere la presenza di glucosio nel sangue. Nel corso del convegno
nella sede ristrutturata di palazzo Baleani, gli interventi di
specialisti sulla materia hanno fatto il punto sull’incremento della
patologia in Italia con focus dedicato alla città di Roma.</p>
<p>In Italia circa il 5% della popolazione è affetta da patologia
diabetica, al Sud più che al Nord (il Lazio si attesta sul 4,9%, di
qualche decimale sopra la media nazionale del 4,6%). Nel quartiere
Parioli la percentuale si attesta intorno al 4% mentre a Tor Bella
Monaca il dato sale al 7%, un dato che deve imporre la massima
attenzione sui cambiamenti socio-sanitari in divenire.</p>
<p><img border="0" src="https://www.comirap.it/images/stories/convegno vitt eman.jpg" style="border: 0px; float: left; margin: 5px;" width="240" /></p>
<p>Il fenomeno è in crescita a livello planetario e non riguarda più
solo i Paesi occidentali ed il benessere ad essi correlato. Sotto
osservazione sono infatti i notevoli incrementi del Messico, della Cina e
dell’Arabia Saudita; in quest’ultima area il rapido e diffuso benessere
prodotto dal petrolio ha cambiato radicalmente lo stile di vita delle
collettività determinando però l’insorgenza del diabete come
conseguenza di una dieta più ricca di grassi, di carboidrati e di
zuccheri. Per quanto riguarda il diabete di tipo 2 vanno tenuti sotto
controllo i valori della glicemia (< 100 e della emoglobina glicata
(<6). La fascia di rischio riguarda valori tra <100/125 per il
glucosio e <6,0/6,4 per l’emoglobina glicata. Si parla di diabete
quando tali valori si attestano intorno al 126 di glucosio e di 6,5 per
la emoglobina glicata.</p>
<p>Queste alcune informazioni in un convegno che ha visto protagoniste la prof.ssa <strong>Raffaella Buzzetti </strong>Direttore UOD Diabetologia, che ha affrontato il tema del diabete mellito e la salute della donna, il dott. <strong>Luca D’Onofrio</strong>, dirigente medico UOD Diabetologia, che ha parlato del diabete mellito come una pandemia cronica, la dott.ssa <strong>Lucia Coraggio</strong>,
dirigente medico UOD Diabetologia, che ha sottolineato l’importanza di
curare il diabete con specifico riferimento alle complicanze croniche
ad esso correlate.</p>
<p>Tra gli interventi dall’audience va segnalato quello del presidente dell’associazione ADA ROMA, <strong>Venanzo Paganelli</strong>,
che ha sottolineato la necessità e l’urgenza di un fronte comune,
associazioni e classe medica, con il coinvolgimento di politici ed
amministratori pubblici, per creare un sistema di prevenzione ampio ed
organizzato, al fine di ridurre con reale efficacia casi e costi
inerenti alla patologia diabetica.</p>
<p>Ribadito dai relatori il concetto fondamentale che il primo contrasto
al diabete va rinvenuto nell’attività fisica (scongiurare la pericolosa
obesità) e nello stile di vita.</p>
<p>Tante le complicanze dovute a questa patologia così complessa; tra
le tante, le problematiche cardio-vascolari, incluso il rischio di
infarto, la retinopatia, la neuropatia e la nefropatia, ma non vanno
sottovalutate le insorgenze di tumori, infezioni, epatopatia che
producono una disabilità funzionale spesso accompagnata da sindrome
depressiva. Neppure trascurabile è la incidenza della paradontite,
malattia infiammatoria orale cronica che distrugge progressivamente le
strutture portanti dei denti. Se l’attività fisica riduce sensibilmente
i rischi connessi alla patologia diabetica, oltre che alla sua
insorgenza, non può mancare la massima attenzione per il regime
alimentare, in cui deve essere basso l’assorbimento di zuccheri ed alto
quello di vegetali, per evitare danni talvolta irreparabili.</p>
<p>Dal palco viene anche il monito a non demonizzare i carboidrati
complessi (pane, pasta e patate), mentre da evitare sono gli zuccheri
semplici (dolci, cornetti, bibite gasate, alcolici, superalcolici).
Bisogna evitare il picco glicemico che danneggia arterie e reni; meglio
iniziare i pasti con verdure. L’invito è ad approfittare della dieta
mediterranea che fa parte del nostro bagaglio territoriale e culturale.</p>
<p>Con l’aumento dell’età le donne presentano un maggior rischio di
sviluppare diabete, che può avere un impatto significativo sulla loro
salute, aumentando il rischio di complicanze sia classiche
(cardiovascolari, oculistiche, neurologiche) sia di più recente
individuazione (osteoporosi, demenza…), mentre non devono essere
sottovalutate la depressione, l’ansia e l’insufficienza renale.
Frequente è lo sviluppo del diabete in gravidanza, anche perché è
sempre in aumento l’età i cui le donne decidono di avere un figlio. E’
stato puntualizzato anche il concetto di suscettibilità genetica per
la trasmissione della malattia, in luogo della familiarità al diabete,
che non ha puntuali basi scientifiche. Anche i soggetti sportivi
possono essere persone affette da diabete; va ricordato, sul punto, che
cortisolo ed adrenalina incidono sull’incremento della glicemia.</p>
<p>Ha preso poi la parola la prof.ssa <strong>Stefania Basili</strong> –
Direttore UOC Immunologia Direzione Sanitaria Policlinico Umberto I,
che con soddisfazione ha illustrato il progetto, finalmente operativo,
legato alla istituzione del Centro per la salute e il benessere della
donna, in cui la paziente è valutata con un approccio olistico, ossia
complessivo, che comporta il coinvolgimento di vari specialisti.</p>
<p>Infine la dott.ssa <strong>Lina Delle Monache</strong> – Presidente
Federdiabete Lazio – ha esposto con molta chiarezza la necessità di una
reale vicinanza alle persone affette da diabete, una dinamica socio
assistenziale in cui le associazioni di volontariato che operano in tale
settore devono trovare un supporto efficace da parte delle istituzioni e
degli apparati pubblici.</p>
<p><strong><a href="https://adaroma.blogspot.com/">Il Blog di ADA ROMA</a></strong></p><div class="attachmentsContainer">
<div class="attachmentsList" id="attachmentsList_com_content_default_1821"></div>
</div></div> <span class="article_separator"><br /></span><p> </p>
<p> </p><br />Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-60198174481043526492024-02-13T10:52:00.000-08:002024-02-13T10:54:02.856-08:00VISITA AREA ARCHEOLOGICA OSPEDALE SAN GIOVANNI ADDOLORATA DI ROMA<p><b>
ECCO A VOI LE DATE DEI PROSSIMI INCONTRI: 17 FEBBRAIO 2024 23 MARZO 2024</b></p><p><b> - LUOGO
INCONTRO: SALA MANZONI, PIAZZA SAN GIOVANNI IN LATERANO, 80 (LATO OBELISCO) </b></p><p><b>- VISITE GRATUITE APERTE ANCHE AI NON SOCI CONDOTTE DAI VOLONTARI DEL GRUPPO
ARCHEOLOGICO ROMANO </b></p><p><b>- ORARIO PARTENZE GRUPPI: 9,30 - 10,30 - 11,30 - 14,30 </b></p><p><b>- OFFERTA LIBERA </b></p><p><b>- LE VISITE SARANNO A NUMERO CHIUSO </b></p><p><b>- SARA' DISTRIBUITO MATERIALE
INFORMATIVO </b></p><p><b>NECESSARIO PRENOTARSI CON INDICAZIONE ORARIO DI PARTENZA:<br />tel.
3358399537</b></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgKMWMYlaENgIxpsnSPWWuDeC1_S8bRRata8iTUTJarLfRzUKhGbBDLJMfZ2nimJZjkTej1tPQdzHzUoTnC-xt-k-vddelg8Cn5QFnDCJsFS0vVPsAjDVz0Zzwjkw4-4s7wzoxf5MyBt0QjRAnNLlkrKMYRhhMwXHxnhaVjRvqLn6tS8uq9m3gxf8H88Ic/s2600/sotterranei%20san%20giovann.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="1784" data-original-width="2600" height="440" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgKMWMYlaENgIxpsnSPWWuDeC1_S8bRRata8iTUTJarLfRzUKhGbBDLJMfZ2nimJZjkTej1tPQdzHzUoTnC-xt-k-vddelg8Cn5QFnDCJsFS0vVPsAjDVz0Zzwjkw4-4s7wzoxf5MyBt0QjRAnNLlkrKMYRhhMwXHxnhaVjRvqLn6tS8uq9m3gxf8H88Ic/w640-h440/sotterranei%20san%20giovann.jpg" width="640" /></a></div><br /><b><br /> </b>
<p></p>Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-2050238484349393532024-02-05T10:35:00.000-08:002024-02-05T10:35:42.257-08:00LA CAMPAGNA DI SCREENING OBESITA' E DIABETE PROMOSSA DA SIPOD APS, PROSEGUE, PER IL 3 ANNO CONFERMATI GLI SCREENING ALL'IIS "CARLO E NELLO ROSSELLI" <div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi6k5XWGTupdnC47ruIoPhJ64eGZlEt-Xn7q6mfezf77Q0fewrmXaFsUhYbkLZmMmoI-bcdfaqNer0vVBNot10lC3msbnTGHQxozEmz_rGTEMjNmlRyVd86I4IM7Qg8eA1acS0wLVeG5P0M4lE5BJ1ncWrDYX9DF7Jb2NRr7E84fAilfXjfv-TZ1Pz3okU/s1600/SIPOT2.png" style="display: block; padding: 1em 0; text-align: center; "><img alt="" border="0" data-original-height="1618" data-original-width="630" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi6k5XWGTupdnC47ruIoPhJ64eGZlEt-Xn7q6mfezf77Q0fewrmXaFsUhYbkLZmMmoI-bcdfaqNer0vVBNot10lC3msbnTGHQxozEmz_rGTEMjNmlRyVd86I4IM7Qg8eA1acS0wLVeG5P0M4lE5BJ1ncWrDYX9DF7Jb2NRr7E84fAilfXjfv-TZ1Pz3okU/s1600/SIPOT2.png"/></a></div>Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-28239320247870036832024-02-03T13:56:00.000-08:002024-02-03T13:56:54.335-08:00DIABETE DI TIPO 1<div class="separator" style="clear: both; text-align: center;"><iframe class="BLOG_video_class" allowfullscreen="" youtube-src-id="4DRf2D9YR5s" width="320" height="266" src="https://www.youtube.com/embed/4DRf2D9YR5s"></iframe></div>Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-49038999153606519362024-02-02T10:53:00.000-08:002024-02-02T10:53:41.367-08:00DIABETE TIPO 1<div class="separator" style="clear: both; text-align: center;"><iframe class="BLOG_video_class" allowfullscreen="" youtube-src-id="pZHRB-_6blI" width="320" height="266" src="https://www.youtube.com/embed/pZHRB-_6blI"></iframe></div>Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-17257354277352518652024-02-01T11:03:00.000-08:002024-02-01T11:03:28.798-08:00RINNOVO PATENTE DI GUIDA PER PAZIENTI DIABETICI<div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjmXGsdSAaZrtQBDwJ837OjEcKhqsoUmkLZMAIcBemi_4q_M2sVrbTVItDEW2fMrOUoe3l0vk1ifGKH-EwY3TvX7VwKv8uBSfqf8dY9QaQv-_v9K5yZcjyS4jrrtvtYovvT1qm49s9L583tT5ryZuL1HQQYrPaIziVRheQ3CrBzN23rxf4bumPfJNpx6aw/s2048/rinnovo%20patente.jpg" style="display: block; padding: 1em 0; text-align: center; "><img alt="" border="0" height="600" data-original-height="2048" data-original-width="1441" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjmXGsdSAaZrtQBDwJ837OjEcKhqsoUmkLZMAIcBemi_4q_M2sVrbTVItDEW2fMrOUoe3l0vk1ifGKH-EwY3TvX7VwKv8uBSfqf8dY9QaQv-_v9K5yZcjyS4jrrtvtYovvT1qm49s9L583tT5ryZuL1HQQYrPaIziVRheQ3CrBzN23rxf4bumPfJNpx6aw/s600/rinnovo%20patente.jpg"/></a></div>Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-47033453404858078692024-01-31T10:41:00.000-08:002024-01-31T10:43:47.045-08:00DIABETE TIPO 1 E SCUOLA<div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi4NNWD_rbGc_ybHi_vuCYSo-i2xTZfWzgKoKfGV4aEuXxxDg9ZkxNHm9ANMAOPsdoKB7Z0svvSx0qAzMkK3M2jOxKcNGjFWe4OKXgLQoQ8FQLWLDNL5r20okSVrnyvSRBngOfPU4q4yRPcePzPQWhx4Kj3DhtFR17n9bvhcsQ6rdaUSYGFMrGsNAPFbQ8/s1600/DIABETE%20TIPO%201%20E%20SCUOLA.jpg" style="display: block; padding: 1em 0; text-align: center; "><img alt="" border="0" height="600" data-original-height="1600" data-original-width="1131" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi4NNWD_rbGc_ybHi_vuCYSo-i2xTZfWzgKoKfGV4aEuXxxDg9ZkxNHm9ANMAOPsdoKB7Z0svvSx0qAzMkK3M2jOxKcNGjFWe4OKXgLQoQ8FQLWLDNL5r20okSVrnyvSRBngOfPU4q4yRPcePzPQWhx4Kj3DhtFR17n9bvhcsQ6rdaUSYGFMrGsNAPFbQ8/s600/DIABETE%20TIPO%201%20E%20SCUOLA.jpg"/></a></div>Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-4109624105717168312024-01-23T10:33:00.000-08:002024-01-23T10:33:25.648-08:00Intervista a Venanzo Paganelli<div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhMHR2NK5bKttQZ4-MBgYdQv29BzH2AXpgD_XJwNsSecGFNfYBXDRUUJcnneB22Ew2bOLkeD6biFRcqhha4H-GDIO4S-bnFN-WhiyyFhhJoKPGthj5_p36lYAq7PvXw4ielgQPRvWRwkSjWJTyJu9IDIcfl9Gc0mG8mh4ovuROExWfZXk7p_EJOdXtYNeU/s1600/intervista_maxi.jpg" style="display: block; padding: 1em 0; text-align: center; "><img alt="" border="0" data-original-height="2500" data-original-width="878" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhMHR2NK5bKttQZ4-MBgYdQv29BzH2AXpgD_XJwNsSecGFNfYBXDRUUJcnneB22Ew2bOLkeD6biFRcqhha4H-GDIO4S-bnFN-WhiyyFhhJoKPGthj5_p36lYAq7PvXw4ielgQPRvWRwkSjWJTyJu9IDIcfl9Gc0mG8mh4ovuROExWfZXk7p_EJOdXtYNeU/s1600/intervista_maxi.jpg"/></a></div>Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-55370235534354833792024-01-05T09:41:00.000-08:002024-01-08T10:06:42.427-08:00<div style="text-align: left;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg8yb2Q_WBEqYpAg_ZF282blZg1k1cgtjaIfTC_b-0HlLDdUp7wxbVEWAX6pwQ8JTubgsFlHTorMG0tdNFEqu_Nb1Vv90cDyvkGvmEp7J8aE5MwzaPnLXtpwZVm-eRiXgFZ5AIYmP-No5kvHDeT-A_rZZ4U3okS-62Wh2RyUDOrRnDSyFpyJfdEvqciUVw/s3296/AIUTA%20IL%20VOLONTARIATO.jpg" style="margin-left: 1em; margin-right: 1em;"></a><br /></div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhRTAmnKiGuT_fcxT5H0A98R8v9IkCqieaU9TQbSqXzSAq82-pwFqExVUn3IC23L2vaHFV1cfdwPc66qAulCkG8-Y1vIcQ-SBXxK_3R7kVswpxxGXkV55Z6N_xfTv9ZMrekGq30PrIvmOZjIm41UBbhJoHzzDMA2Dln0kRqFZqCCVLNE5DXp8Zd0rbNz8I/s3296/AIUTA%20IL%20VOLONTARIATO.jpg" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="3296" data-original-width="2384" height="762" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhRTAmnKiGuT_fcxT5H0A98R8v9IkCqieaU9TQbSqXzSAq82-pwFqExVUn3IC23L2vaHFV1cfdwPc66qAulCkG8-Y1vIcQ-SBXxK_3R7kVswpxxGXkV55Z6N_xfTv9ZMrekGq30PrIvmOZjIm41UBbhJoHzzDMA2Dln0kRqFZqCCVLNE5DXp8Zd0rbNz8I/w550-h762/AIUTA%20IL%20VOLONTARIATO.jpg" width="550" /></a></div><br /><p style="text-align: left;"></p><div class="separator" style="clear: both; text-align: center;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiNvJ-YNjHDcSmgVMtZJicX8hRQ_jCa4fHGst0VEt7wVUPiP2ZUvxyG60TJhiRljh9Rw6Wf_hNC66qeJ77Fb7KJTSSd-g0VX3SKbvDniq9hBpsxzuAixZN5tpy6Q9wSfExBbn76OnhXgpawthOp26Sez1ilvyc7lIT-0eWDT5aJ6pJXmP2rIkhdIJ_TDs4/s2416/VOLANTINO%20ADA%201.jpg" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="2416" data-original-width="2408" height="310" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiNvJ-YNjHDcSmgVMtZJicX8hRQ_jCa4fHGst0VEt7wVUPiP2ZUvxyG60TJhiRljh9Rw6Wf_hNC66qeJ77Fb7KJTSSd-g0VX3SKbvDniq9hBpsxzuAixZN5tpy6Q9wSfExBbn76OnhXgpawthOp26Sez1ilvyc7lIT-0eWDT5aJ6pJXmP2rIkhdIJ_TDs4/w309-h310/VOLANTINO%20ADA%201.jpg" width="309" /></a><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhe7LLHR31KhB56uvNoit2JNALieGIWyvUf1MLUcGdqPFbTBpz1c_Z742cuII380MN9CEWBR7wfreqolIY1kRyBa2IAoLxrTMYzGloH6AVCT_dalDhyphenhyphen6cxRShZYyxh7JJVNFl5HEmTS9_9tNhyphenhyphen99PxTNDxxEnW-Z5xfAvW1Pazy_QdbusdTbt-1CLDAq4I/s2488/VOLANTINO%20ADA%202.jpg" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="2488" data-original-width="2360" height="312" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhe7LLHR31KhB56uvNoit2JNALieGIWyvUf1MLUcGdqPFbTBpz1c_Z742cuII380MN9CEWBR7wfreqolIY1kRyBa2IAoLxrTMYzGloH6AVCT_dalDhyphenhyphen6cxRShZYyxh7JJVNFl5HEmTS9_9tNhyphenhyphen99PxTNDxxEnW-Z5xfAvW1Pazy_QdbusdTbt-1CLDAq4I/w295-h312/VOLANTINO%20ADA%202.jpg" width="295" /></a></div></div><br /><p></p>Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-1114209271593718082023-12-31T04:08:00.000-08:002024-01-08T10:07:16.205-08:00<p style="text-align: center;"><span style="color: #2b00fe;">AUGURO A TUTTI I SOCI BUON ANNO </span><br /></p><p> Voglio segnalarVi che, per il prossimo anno, uno degli obiettivi più impotanti della nostra Associazione, è quello di far si che la Regione Lazio dia attuazione, al </p><p style="text-align: center;">" <u>PIANO PER LA MALATTIA DIABETICA NELLA REGIONE LAZIO 2016 - 2018"</u><br /></p><p style="text-align: center;"> Venanzo Paganelli Presidente</p><p style="text-align: center;"> ADA ROMA - ASSOCIAZIONE DIABETICI - ODV<br /></p><p> Nel link sottostante è riportato integralmente Il Piano per la Malattia Diabetica</p><p><a href="https://www.anaao.lazio.it/index.php?option=com_dropfiles&format=&task=frontfile.download&catid=90&id=255&Itemid=1000000000000" target="_blank">https://www.anaao.lazio.it/index.php?option=com_dropfiles&format=&task=frontfile.download&catid=90&id=255&Itemid=1000000000000</a><br /><a href=" file:///C:/Users/Windows%2010/Documents/PIANO%20REGIONALE%20SUL%20DIABETE.pdf"> </a></p>Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-3838878334363364942023-12-23T10:23:00.000-08:002024-01-08T10:07:24.145-08:00<p> </p><p style="text-align: justify;"> </p>
<p> </p>
<p style="margin-left: 40px; text-align: justify;"><b><span style="font-size: medium;">Il farmaco, che nei casi di ipoglicemia grave, consente di
ristabilire il livello di zuccheri nel sangue del giovane paziente con
un semplice spruzzo nel naso, diventa rimborsabile</span></b></p>
<p> </p>
<p> </p>
<p>La Regione Lazio garantirà, attraverso le Aziende sanitarie, lo spray
nasale di Glucagone ai bambini e agli adolescenti in età scolare (4-18
anni) affetti da diabete mellito di tipo I. Con la recente
determinazione adottata dal direttore della Direzione Salute e
Integrazione sociosanitaria della Regione Lazio, Andrea Urbani, i
pazienti diabetici, a rischio di grave ipoglicemia, potranno migliorare
sensibilmente la qualità della loro vita, nell’ambito della gestione
della malattia.</p>
<p>Il Glucagone è infatti l’unico farmaco che, in caso di ipoglicemia
grave, consente di ristabilire il livello di zuccheri nel sangue del
paziente con un semplice spruzzo nel naso, assicurando un’agevole e
un’imminente somministrazione anche negli ambienti extra sanitari, a
partire dal mondo della scuola. Si tratta di una risposta tempestiva
alle esigenze di salute dei bambini e degli adolescenti diabetici, in
linea con le richieste delle associazioni dei pazienti. Un provvedimento
che riassume il forte impegno della Regione Lazio a mantenere un
livello elevato e qualitativo dell’assistenza sanitaria.</p>
<p>La notizia tanto attesa dalle associazioni delle persone diabetiche, è
finalmente arrivata: il Glucagone da fascia C torna in fascia A, quella
che ne garantisce la rimborsabilità ai giovani pazienti di diabete 1.</p>
<p>Grande soddisfazione del presidente di ADA ROMA - Associazione Diabetici Addolorata, <strong>Venanzo Paganelli: </strong>"confidavamo
che la Regione Lazio si allineasse con quanto già fatto dalle regioni
Emilia-Romagna, Piemonte, Liguria, Sicilia e Campania, che avevano
provveduto a rendere rimborsabile lo spray salvavita per i giovani
diabetici di tipo 1".</p>
<p>Si ricorda che tale farmaco, importante perchè utilizzato anche nelle
scuole ove può essere somministrato evitando le iniezioni, era
disponibile in Italia fin dal 2020 allorchè fu inserito in fascia A,
quindi rimborsabile dal S.S.N. ma poi era tornato in fascia C, a
pagamento, perchè l'azienda farmaceutica multinazionale che lo aveva
prodotto lo aveva venduto ad altra che però non aveva sede nel nostro
Paese. Interessati all'utilizzo del farmaco spray salvavita sono circa
mille alunni nel Lazio: il prodotto costa cento euro a confezione.</p>
<p><a href="https://www.comirap.it/Riportiamo una lettera di Diabete Italia indirizzata al direttore del Quotidiano Sanità sul tema del Glucagone spray, un farmaco salvavita inserito in fascia C e quindi disponibile solo a pagamento! (comirap.it)"><strong><br /></strong></a></p><div class="attachmentsContainer">
<div class="attachmentsList" id="attachmentsList_com_content_default_1790"></div>
</div>
<span class="modifydate">
Ultimo aggiornamento Sabato 23 Dicembre 2023 17:25 </span><span class="article_separator"><br /></span>Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-47230758871858252292023-12-14T01:44:00.000-08:002024-01-08T10:09:11.403-08:00Festa del Volontariato Ospedale San Giovanni di Roma<p> </p><div class="separator" style="clear: both; text-align: center;"></div><div class="separator" style="clear: both; text-align: center;"></div><div class="separator" style="clear: both; text-align: center;"><iframe allowfullscreen="" class="BLOG_video_class" height="266" src="https://www.youtube.com/embed/0w1d_H4XpK8" width="320" youtube-src-id="0w1d_H4XpK8"></iframe></div><br /><p></p>Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-31323994527666472292021-06-27T11:44:00.000-07:002024-01-08T10:08:57.955-08:00<p> <span style="font-family: arial; font-size: large;">Vi comunichiamo il testo del verbale dell'assemblea dei soci ADA con l'invito a tutti i soci a partecipare alle attività dell'Associazione per assicurare quel rinnovamento necessario in tutte le associazioni. Chi volesse dare la sua disponibilità può comunicarlo alla mail dell'ADA:</span></p><p><span style="font-family: arial; font-size: large;">diabeteadaroma@gmail.com</span></p><p><br /></p><p><br /></p><p><br /></p><p class="MsoNormal"><span style="font-size: 14.0pt;">Roma, 27 maggio 2021 <o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size: 14.0pt;"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size: 14.0pt;"><span style="mso-spacerun: yes;"> </span>VERBALE
ASSEMBLEA<span style="mso-spacerun: yes;"> </span>ANNUALE 2021<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size: 14.0pt;"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size: 14.0pt;">Il giorno 27 maggio 2021 alle
ore 15,00<span style="mso-spacerun: yes;"> </span>si è svolta presso la sala
d’attesa del Centro Diabetologico del Presidio Santa Maria in via San Giovanni
in Laterano 155 – Roma, l’Assemblea<span style="mso-spacerun: yes;"> </span>annuale
dell’Associazione ADA Roma “Associazione Diabetici<span style="mso-spacerun: yes;"> </span>O.D.V.”,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size: 14.0pt;">regolarmente convocata con il
seguente <o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size: 14.0pt;"><span style="mso-spacerun: yes;"> </span>ORDINE<span style="mso-spacerun: yes;"> </span>DEL<span style="mso-spacerun: yes;">
</span>GIORNO:<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size: 14.0pt;"><o:p> </o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt; mso-list: l0 level1 lfo1; text-indent: -18.0pt;"><!--[if !supportLists]--><span style="font-size: 14.0pt; mso-bidi-font-family: "Times New Roman"; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;">1-<span style="font: 7.0pt "Times New Roman";">
</span></span></span><!--[endif]--><span style="font-size: 14.0pt;">Relazione del
Presidente sull’attività svolta dall’Associazione nell’anno 2020<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt; mso-list: l0 level1 lfo1; text-indent: -18.0pt;"><!--[if !supportLists]--><span style="font-size: 14.0pt; mso-bidi-font-family: "Times New Roman"; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;">2-<span style="font: 7.0pt "Times New Roman";">
</span></span></span><!--[endif]--><span style="font-size: 14.0pt;">Bilancio 2020:
discussione e approvazione<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt; mso-list: l0 level1 lfo1; text-indent: -18.0pt;"><!--[if !supportLists]--><span style="font-size: 14.0pt; mso-bidi-font-family: "Times New Roman"; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;">3-<span style="font: 7.0pt "Times New Roman";">
</span></span></span><!--[endif]--><span style="font-size: 14.0pt;">Presentazione
programma per l’anno 2021<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt; mso-list: l0 level1 lfo1; text-indent: -18.0pt;"><!--[if !supportLists]--><span style="font-size: 14.0pt; mso-bidi-font-family: "Times New Roman"; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;">4-<span style="font: 7.0pt "Times New Roman";">
</span></span></span><!--[endif]--><span style="font-size: 14.0pt;">Votazione per il
rinnovo del Consiglio Direttivo<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt; mso-list: l0 level1 lfo1; text-indent: -18.0pt;"><!--[if !supportLists]--><span style="font-size: 14.0pt; mso-bidi-font-family: "Times New Roman"; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;">5-<span style="font: 7.0pt "Times New Roman";">
</span></span></span><!--[endif]--><span style="font-size: 14.0pt;">Varie ed
eventuali.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;"><o:p> </o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;"><o:p> </o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt; mso-list: l1 level1 lfo2; text-indent: -18.0pt;"><!--[if !supportLists]--><span style="font-size: 14.0pt; mso-bidi-font-family: "Times New Roman"; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;">1)<span style="font: 7.0pt "Times New Roman";">
</span></span></span><!--[endif]--><span style="font-size: 14.0pt;">Il Presidente
Paganelli legge la relazione sull’attività svolta nel corso dell’anno 2020.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;">Nell’anno
2020 che è stato caratterizzato dalle restrizioni a causa del COVID, l’attività
dell’Associazione<span style="mso-spacerun: yes;"> </span>è stata limitata ed è
stata esclusa la presenza dei volontari presso il Centro diabetologico.<span style="mso-spacerun: yes;"> </span>L’Assemblea annuale 2020 si è svolta in
modalità<span style="mso-spacerun: yes;"> </span>on-line, ed allo stesso modo
l’altra assemblea per approvare il bilancio 2019.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;">Nonostante
le criticità, un gran numero di soci ha continuato a sostenere l’ADA con <span style="mso-spacerun: yes;"> </span>il rinnovo delle quote associative e
devolvendo il<span style="mso-spacerun: yes;"> </span>5 per mille a favore
dell’Associazione nella dichiarazione dei redditi.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;">Il
Presidente informa che è stata attivata la PEC (posta elettronica certificata
che assicura sicurezza e valore legale nella trasmissione di comunicazioni e
documenti); che si è provveduto ad informare i soci sulle modalità relative
alle vaccinazioni prevalentemente tramite whats app ; e che è stata data la ns.
disponibilità<span style="mso-spacerun: yes;"> </span>alla Direzione del Centro
diabetologico in occasione delle vaccinazioni in sede.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;">Paganelli
dà lettura di un questionario, frutto della collaborazione tra<span style="mso-spacerun: yes;"> </span>lui ed alcuni soci, predisposto con lo scopo
di attirare l’attenzione soprattutto dei giovani e sollecitarli ad entrare a
fare parte attivamente dell’associazione. Il questionario dovrà essere
consegnato dalle Dott.sse al paziente al termine della visita: la
compilazione<span style="mso-spacerun: yes;"> </span>è anonima, ma è importante
al fine di individuare richieste e raccogliere proposte e candidature.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;">Sul
contenuto del questionario vengono sollevate delle obiezioni da alcuni soci.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;">Viene
così deciso di modificare il testo dell’ultima domanda per non ingenerare
ambiguità nell’interpretazione.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt; mso-list: l1 level1 lfo2; text-indent: -18.0pt;"><!--[if !supportLists]--><span style="font-size: 14.0pt; mso-bidi-font-family: "Times New Roman"; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;">2)<span style="font: 7.0pt "Times New Roman";">
</span></span></span><!--[endif]--><span style="font-size: 14.0pt;">Il Presidente
legge e illustra il bilancio 2020 che viene approvato all’unanimità.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt; mso-list: l1 level1 lfo2; text-indent: -18.0pt;"><!--[if !supportLists]--><span style="font-size: 14.0pt; mso-bidi-font-family: "Times New Roman"; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;">3)<span style="font: 7.0pt "Times New Roman";">
</span></span></span><!--[endif]--><span style="font-size: 14.0pt;">Paganelli
prosegue leggendo il programma per il 2021.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;">Per
fare conoscere la ns. Associazione è necessario attingere a nuove risorse
umane. Per questo invita i presenti a collaborare e a cercare altre persone che
si impegnino. Paganelli sostiene che è importante ed indispensabile per la
crescita dell’ADA , che siano i giovani a guidare questo nuovo corso di
rinnovamento.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;">Quest’anno
<span style="mso-spacerun: yes;"> </span>grazie ai fondi del 5 per mille, l’Associazione
potrà finanziare, con un importo di 800,00 euro,<span style="mso-spacerun: yes;"> </span>il <span style="mso-spacerun: yes;"> </span>podologo presso il Centro diabetologico per
continuare il monitoraggio dei pazienti diabetici, iniziato <span style="mso-spacerun: yes;"> </span>nel 2019 : <span style="mso-spacerun: yes;"> </span>un’attività di prevenzione importantissima
per<span style="mso-spacerun: yes;"> </span>la prevenzione delle complicanze del
piede. <span style="mso-spacerun: yes;"> </span>La proposta verrà presentata alla
Direzione generale. <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;">Paganelli
si riserva di chiedere alla Dir. Gen. che venga assegnato anche <span style="mso-spacerun: yes;"> </span>uno psicologo al Centro come da più parti
richiesto. Alcuni soci suggeriscono di fare dei gruppi di ascolto tra i
pazienti, <span style="mso-spacerun: yes;"> </span>per condividere le difficoltà
personali e aiutare a superarle.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;">La
sig.ra Santarelli propone di fare dei corsi rivolti ai familiari dei pazienti
per istruirli sui comportamenti da adottare in situazioni critiche ( ipoglicemie)
<span style="mso-spacerun: yes;"> </span>e sull’utilizzo del glucometro nel
controllo delle glicemie.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;">Paganelli
informa della convenzione ( pari a 25,00 euro)<span style="mso-spacerun: yes;">
</span>con il podologo Fantauzzi<span style="mso-spacerun: yes;"> </span>per i
soci dell’Associazione.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;">Prosegue
con l’assegnazione di alcuni incarichi fra i soci presenti.<span style="mso-spacerun: yes;"> </span>Alcuni si occuperanno della gestione dei
social ( facebook, blog, whatsapp) ,<span style="mso-spacerun: yes;">
</span>altri dell’ aggiornamento della lista dei soci ed altri si aggiungeranno
ai volontari nella presenza al Centro durante la settimana.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt; mso-list: l1 level1 lfo2; text-indent: -18.0pt;"><!--[if !supportLists]--><span style="font-size: 14.0pt; mso-bidi-font-family: "Times New Roman"; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;">4)<span style="font: 7.0pt "Times New Roman";">
</span></span></span><!--[endif]--><span style="font-size: 14.0pt;">L a riunione
prosegue dando corso alla votazione per il rinnovo delle cariche sociali. Al
termine delle votazioni risultano eletti i seguenti candidati:<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;">Bianconi
Sandra; Coltellacci Paola; D’Aprile Francesco; Di Nardi Emidia; Mellina Alba
Silvia; Nieddu Maria; Notarangelo Dario; Paganelli Venanzo; Santarelli Concita;
Timperi Gianluigi.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;">Terminati
gli argomenti all’o.d.g.<span style="mso-spacerun: yes;"> </span>alle ore 17,30
si concludono i lavori dell’Assemblea annuale <span style="mso-spacerun: yes;"> </span>ADARoma.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size: 14.0pt;"><span style="mso-spacerun: yes;"> </span><span style="mso-spacerun: yes;"> </span><o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;"><span style="mso-spacerun: yes;">
</span>In fede<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;"><o:p> </o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;">Il
segretario<span style="mso-spacerun: yes;">
</span>Il Presidente<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 36.0pt;"><span style="font-size: 14.0pt;">Maria
Nieddu<span style="mso-spacerun: yes;"> </span><span style="mso-spacerun: yes;"> </span>Venanzo Paganell<o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b style="mso-bidi-font-weight: normal;"><span style="mso-spacerun: yes;"> </span><o:p></o:p></b></p>Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-55144668570044027642021-06-09T10:50:00.000-07:002024-01-08T10:09:22.131-08:00<p><span style="color: #2b00fe; font-size: x-large;"><b style="background-color: white;"><span> </span><span> </span><span> </span>CONVENZIONE PODOLOGO<br /><span> </span><span> </span><span> </span><span> </span>PER I SOCI ADAROMA</b></span></p><p><br /></p><p><span style="font-size: large;">L'Associazione comunica ai soci che il Dott. <b>Claudio Fantauzzi</b>, podologo specialista in prevenzione e trattamento del piede diabetico (Iscrizione Albo podologi di Roma nr. 86), si impegna a trattare in convenzione gli iscritti all'ADARoma presso il proprio Studio Podologico di Roma, situato in:<br /><br />Via Virgilio Melandri 112 (zona Palmiro-Togliatti-Collatina). </span></p><p><span style="font-size: large;">Il costo per il trattamento podologico di base è quantificato in euro 25,00, anzichè 35,00.<br /><br /><br /><b><span style="color: #2b00fe;">Contatti:</span></b><br /><span style="color: #2b00fe;">cell.: </span>346 6748781<br /><span style="color: #2b00fe;">studio:</span> 351 6929983<br /><span style="color: #2b00fe;">mail:</span> fantapakk@libero.it </span></p>Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-32089533330350054552020-09-25T07:05:00.000-07:002024-01-08T10:09:35.873-08:00<p><span style="font-size: large;">Progetto di screening per la prevenzione del piede diabetico</span></p><p> 15 settembre 2020</p><p><br /></p><p>A cura del Dott. Claudio Fantauzzi, Podologo, Tivoli Terme (Roma)</p><p>Resoconto di un progetto di screening per la prevenzione del piede diabetico condotto presso la UOSD Diabetologia dell'Ospedale San Giovanni Addolorata di Roma.</p><p>Potete collegarvi al seguente link per visionare l'intero progetto e gli importanti risultati dell'indagine svolta</p><p>https://www.diabete.com/progetto-di-screening-per-la-prevenzione-del-piede-diabetico.</p><p><br /></p><p> <span style="font-size: large;">CONVOCAZIONE ASSEMBLEA ANNUALE </span></p><p><span style="font-size: large;"> E' stata indetta l'assemblea annuale ADARoma in data 30 settembre 2020, alle ore 16,30. L'invito alla partecipazione è stato spedito via email. La seduta si terrà non in presenza, ma attraverso il collegamento on line, la cui modalità di accesso è già stata comunicata unitamente alla email di convocazione.</span></p><p><span style="font-size: large;">Invitiamo tutti i soci a partecipare on-line all'assemblea, oppure inviando una delega via e-mail; in alternativa è possibile inviare la delega via whatsapp direttamente al presidente Venanzo Paganelli indicando il delegato. </span></p><p><span style="font-size: large;">Per la delega, domande o chiarimenti inviare una email alla Associazione scrivendo a: diabeteadaroma@gmail.com.</span></p><p>.La vostra presenza è importante per ricevere notizie della nostra Associazione anche in questo periodo di limitazioni. Con la partecipazione attiva, ciascuno di noi può dare il suo contributo.</p><p></p><div class="separator" style="clear: both; text-align: center;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi1LSK55Sm_2R3x2MP72UGCEfzC7FLS6em0Kh5nAOWMWyP6nvdSy0NzYjJIZqEubylgbSoWh8XNMeS2uJa50DbRuzOpebM4OymvaP8Qb9mrnQeFRUNQ0B-EE1D47rCMRIY9CUHYXfR7uKY/" style="margin-left: 1em; margin-right: 1em;"><img alt="" data-original-height="800" data-original-width="581" height="423" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi1LSK55Sm_2R3x2MP72UGCEfzC7FLS6em0Kh5nAOWMWyP6nvdSy0NzYjJIZqEubylgbSoWh8XNMeS2uJa50DbRuzOpebM4OymvaP8Qb9mrnQeFRUNQ0B-EE1D47rCMRIY9CUHYXfR7uKY/w307-h423/foto2.jpg" width="307" /></a></div><br /><br /></div><div class="separator" style="clear: both; text-align: center;"><br /></div><div class="separator" style="clear: both; text-align: center;">La collaborazione tra Regione Lazio e Associazioni di pazienti premia.</div><div class="separator" style="clear: both; text-align: center;">L'articolo riguarda il respingimento dell'istanza presentata da un vasto elenco di laboratori privati che si ritenevano danneggiati dal decreto n. 71 del Commissario della Regione Lazio relativo all'applicazione delle stesse tariffe del servizio pubblico a quelle private. </div><div class="separator" style="clear: both; text-align: center;"><br /></div><div class="separator" style="clear: both; text-align: center;"><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;">**SANITA': LAZIO, TAR RESPINGE ISTANZA LABORATORI PRIVATI SU NOMENCLATORE TARIFFARIO** =</span><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;"> D'Amato, 'grazie a supporto pazienti, diamo quadro di certezza a</span><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;">programmazione regionale'</span><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;"> Milano, 15 set. (Adnkronos Salute) - Il Tar del Lazio ha respinto</span><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;">l'istanza cautelare presentata da numerosi laboratori privati che</span><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;">chiedevano la sospensione del decreto n. 71 del commissario ad acta</span><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;">della Regione Lazio, relativo al Nomenclatore tariffario e</span><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;">all'estensione dell'erogabilità delle prestazioni di assistenza</span><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;">specialistica ambulatoriale senza ulteriori oneri a carico del</span><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;">bilancio regionale.</span><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;"> "In giudizio sono intervenute ad adiuvandum dell'amministrazione</span><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;">regionale numerose associazioni dei pazienti e dei malati che voglio</span><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;">ringraziare", afferma l'assessore alla Sanità e Integrazione socio</span><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;">sanitaria, Alessio D'Amato. "Questo pronunciamento, seppur in attesa</span><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;">di una discussione di merito - commenta - è importante per dare un</span><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;">quadro di certezze nella programmazione sanitaria regionale".</span><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><br style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;" /><span style="font-family: -apple-system, BlinkMacSystemFont, "Helvetica Neue", "Segoe UI", Arial, sans-serif; font-size: 13px; text-align: start;"> (Com-Opa/Adnkronos Salute)</span></div><p></p>Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-35489999382698966992020-06-16T01:17:00.000-07:002024-01-08T10:32:50.988-08:00RINNOVO PATENTE<div style="text-align: center;">
<b>CENTRO DIABETOLOGICO S.GIOVANNI- ADDOLORATA</b></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
INFORMAZIONI PER IL RINNOVO PATENTE PAZIENTI DIABETICI</div>
<div style="text-align: justify;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj5IesuTSoECzDzORFambT8-G7xxkH7vuVuRkzcvgebp1oUx6zOJ2jxqM7bSypcx7sdRi7107keX3afB33AGWf-pXZ7u_UcCKkweUAcEnqHG9a1PSKwYIWDBVj9wrfgn6zS3mtKcQNexjE/s1600/img1.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1068" data-original-width="751" height="640" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj5IesuTSoECzDzORFambT8-G7xxkH7vuVuRkzcvgebp1oUx6zOJ2jxqM7bSypcx7sdRi7107keX3afB33AGWf-pXZ7u_UcCKkweUAcEnqHG9a1PSKwYIWDBVj9wrfgn6zS3mtKcQNexjE/s640/img1.png" width="450" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
MODALITA' PER PRENOTARE LA VISITA DIABETOLOGICA PER IL RILASCIO DEL CERTIFICATO PER IL RINNOVO PATENTE</div>
<div style="text-align: justify;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjScCdWvjQupf22i6PhoiT3Zj-KzeAZj7RXEijygdVvZsPoMyoMm4XbRy49W4X4FOB4D7mpkDeIwcDnNLg8Ik5ZDNP_ZEz3UAN1koP8qiBjbuzRs44VG-Vh7Esvj51ypsH5UhRE31v4V9Y/s1600/img2.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1600" data-original-width="1071" height="640" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjScCdWvjQupf22i6PhoiT3Zj-KzeAZj7RXEijygdVvZsPoMyoMm4XbRy49W4X4FOB4D7mpkDeIwcDnNLg8Ik5ZDNP_ZEz3UAN1koP8qiBjbuzRs44VG-Vh7Esvj51ypsH5UhRE31v4V9Y/s640/img2.png" width="428" /></a></div>
<div style="text-align: justify;">
<br /></div>
Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-80881804461901125462020-05-05T04:02:00.000-07:002024-01-08T10:52:57.811-08:00<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: left;">
Modifiche allo Statuto dell 'Associazione ADARoma iscritta nel Registro Ufficiale della Regione Lazio delle Associazioni ODV.</div>
<div class="separator" style="clear: both; text-align: left;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjnO_eRuFurLp2vz2y4WRBfo0_zt4rgZuyHbWCiN3kSfDhGQw9GN3XD6nEjWirmE6TokthLQQReoHPJYA3rGds7pRIF6pSKro17OwMH9LTPAQydM1jVwcL1iQ5-z13uxeB78e9YlgYHOtQ/s1600/stat1.PNG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="642" data-original-width="452" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjnO_eRuFurLp2vz2y4WRBfo0_zt4rgZuyHbWCiN3kSfDhGQw9GN3XD6nEjWirmE6TokthLQQReoHPJYA3rGds7pRIF6pSKro17OwMH9LTPAQydM1jVwcL1iQ5-z13uxeB78e9YlgYHOtQ/s320/stat1.PNG" width="225" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiDXeqAT3zwkRFRi3ZJsTtZHgH_VfeA2IOD9RzNqRDTXunlrPCkzaE9ITSCXgLkFIdyWKU-DTGe-8Ee-auqpBepEqLC5hyphenhyphenVXbHO_3R2RIlEWaNzhgDLARieYw6FWgEOJgcdBfHjM0Z1NSA/s1600/stat2.PNG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="628" data-original-width="442" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiDXeqAT3zwkRFRi3ZJsTtZHgH_VfeA2IOD9RzNqRDTXunlrPCkzaE9ITSCXgLkFIdyWKU-DTGe-8Ee-auqpBepEqLC5hyphenhyphenVXbHO_3R2RIlEWaNzhgDLARieYw6FWgEOJgcdBfHjM0Z1NSA/s320/stat2.PNG" width="225" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEggEb7S-3giSKEOh7e0q6JaV50pS-tUkv9M8zf-3nb2QGtVihz7ritTM6ZdRcDCyU2-YCSe93rmdlGCChWidYwozmycV7Db2LMaBGEI8tWTm6vgJ-bJhtKh2qATw2yVZBS4GdQfi-Du7VY/s1600/stat3.PNG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="602" data-original-width="443" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEggEb7S-3giSKEOh7e0q6JaV50pS-tUkv9M8zf-3nb2QGtVihz7ritTM6ZdRcDCyU2-YCSe93rmdlGCChWidYwozmycV7Db2LMaBGEI8tWTm6vgJ-bJhtKh2qATw2yVZBS4GdQfi-Du7VY/s320/stat3.PNG" width="235" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEicj5W7R2-pKPRCvAYMSVYVLS-PAm8eAPIMbYNKkoCNNtLa9wF9kOOXhhZM0LNJ4k0_BkEKgzIerfiIK-odhD5Jf0kCysQLHT4Ls0mYX54SxefCEx25GY3z2Gzs3tPXUa9kqcvMcByiuCs/s1600/stat4.PNG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="617" data-original-width="429" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEicj5W7R2-pKPRCvAYMSVYVLS-PAm8eAPIMbYNKkoCNNtLa9wF9kOOXhhZM0LNJ4k0_BkEKgzIerfiIK-odhD5Jf0kCysQLHT4Ls0mYX54SxefCEx25GY3z2Gzs3tPXUa9kqcvMcByiuCs/s320/stat4.PNG" width="222" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEia7vX5HdzBjtn3gtYI6e58fSfZQcztclVSdj958jhydUN0m2MBo_JB3yIfac2Qc3ObteQ7596TAJvFIhyphenhyphen_9ctQptxECl2IUOlpeGvG4Ly6Xdc_crMVDezUd1iR4qp5KfX09CBajGme9tc/s1600/stat5.PNG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="581" data-original-width="404" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEia7vX5HdzBjtn3gtYI6e58fSfZQcztclVSdj958jhydUN0m2MBo_JB3yIfac2Qc3ObteQ7596TAJvFIhyphenhyphen_9ctQptxECl2IUOlpeGvG4Ly6Xdc_crMVDezUd1iR4qp5KfX09CBajGme9tc/s320/stat5.PNG" width="222" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi0X_yQ999ApVXK12h_hW21Ylf-At9abwwRw992pmm5udyGOFGpC-3WqSIg_lf9PnXzOxfrrOUgEnnN95U9bjoVtH6LXY-XvrRLGVl7vUVopGpSFFWWwnG4FtM2Tz48D4MGKwJHUcpbwJY/s1600/stat6.PNG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="590" data-original-width="422" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi0X_yQ999ApVXK12h_hW21Ylf-At9abwwRw992pmm5udyGOFGpC-3WqSIg_lf9PnXzOxfrrOUgEnnN95U9bjoVtH6LXY-XvrRLGVl7vUVopGpSFFWWwnG4FtM2Tz48D4MGKwJHUcpbwJY/s320/stat6.PNG" width="228" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjxBFegQzvixeg9fQol3CgcHspu1AlB1pKKXgzxX2QX8CmC_PTbhRLJ0ZJbMmzNoLDOe_mVC2W9nF87vkbctJmpkL9tkaMu-moQiLi_y22eq_Z30jC8bxungLXV7sTpA0RSRuDgA8_b55g/s1600/stat7.PNG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="582" data-original-width="423" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjxBFegQzvixeg9fQol3CgcHspu1AlB1pKKXgzxX2QX8CmC_PTbhRLJ0ZJbMmzNoLDOe_mVC2W9nF87vkbctJmpkL9tkaMu-moQiLi_y22eq_Z30jC8bxungLXV7sTpA0RSRuDgA8_b55g/s320/stat7.PNG" width="232" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiuswnIif3Dph6ITYm2W-I8Lizb6Bo9tmv6wxfEw56Eu1ukb2YheLQvW85U3Liao2VBbp3gRxGauf247O2wnakjBRn3KTAQd-f6mOrgeDN3gw953tkGJzKBJks9oEvbkUcGSROpAZEv908/s1600/stat8.PNG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="583" data-original-width="426" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiuswnIif3Dph6ITYm2W-I8Lizb6Bo9tmv6wxfEw56Eu1ukb2YheLQvW85U3Liao2VBbp3gRxGauf247O2wnakjBRn3KTAQd-f6mOrgeDN3gw953tkGJzKBJks9oEvbkUcGSROpAZEv908/s320/stat8.PNG" width="233" /></a></div>
<br />Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-19089723129098380622020-05-05T03:14:00.000-07:002024-01-08T10:53:12.489-08:00 DISPOSIZIONI DALLA REGIONE LAZIO.<div>
<br /></div>
<div>
<br /></div>
<div>
<br /></div>
<div>
In ottemperanza alle disposizioni della Regione Lazio dettate per l'emergenza del COVID-19, </div>
<div>
gli ambulatori del Centro Diabetologico dell'Azienda Ospedaliera S.Giovanni-Addolorata Presidio Santa Maria in Via S.Giovanni in Laterano 155 - Roma, rimarranno chiusi per le visite di controllo ad eccezione di quelle urgenti, fino al 31 maggio 2020. </div>
<div>
Tutti coloro i quali hanno prenotata la visita di controllo nel mese di maggio, verranno contattati dal personale infermieristico per fissare un nuovo appuntamento.</div>
Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-63595968804099317202020-03-12T11:58:00.000-07:002024-01-08T10:53:30.809-08:00Regione Lazio : emergenza COVID - 19 <b>REGIONE LAZIO : EMERGENZA COVID -19</b><br />
<br />
<br />
Queste le importanti disposizioni da parte della Regione Lazio relative ai piani terapeutici in scadenza dal mese di marzo che saranno rinnovati per <b>90 gg</b>.<br />
Le attività ambulatoriali <u>sono sospes</u>e, eccezion fatta per le visite descritte dettagliatamente nel documento (scarica il documento da questo <a href="http://www.ordinefarmacistiroma.it/wp-content/uploads/2020/03/1250-REG-1583951893649-piani-terap-3-002.pdf" target="_blank">link</a>).<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj4a52j9iCwg4_BTU6fGpQeGw6f8C9M-KUAGdTxlTSRj6NQHDOz0Jo1leyjpXZ7yKhCGw__xeIPtrVv4W0bpi9GuhWSt-b40EZoduYZ1GURScbw8Y8g4GW0TocIDLADE3aTPwZUtndwNqE/s1600/Cattura1.PNG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="647" data-original-width="500" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj4a52j9iCwg4_BTU6fGpQeGw6f8C9M-KUAGdTxlTSRj6NQHDOz0Jo1leyjpXZ7yKhCGw__xeIPtrVv4W0bpi9GuhWSt-b40EZoduYZ1GURScbw8Y8g4GW0TocIDLADE3aTPwZUtndwNqE/s1600/Cattura1.PNG" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiP-g1g-JBxomMQFQbq74R5e-nc_4I6FrrgOn2pNlvazXX9Eh40VQxc21hUXres3y6zfyC89B1T_MTAGgNhP-mSWKyNY939elB9Xkx9ED49KrRgBOkkQLGjR-hdEy9LaYTzWqbX_nwa-YY/s1600/Cattura2.PNG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="635" data-original-width="495" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiP-g1g-JBxomMQFQbq74R5e-nc_4I6FrrgOn2pNlvazXX9Eh40VQxc21hUXres3y6zfyC89B1T_MTAGgNhP-mSWKyNY939elB9Xkx9ED49KrRgBOkkQLGjR-hdEy9LaYTzWqbX_nwa-YY/s1600/Cattura2.PNG" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhEwVALGMpHU8EKrIKYxQmLdmlkEmVITwNHCuxu73sygW8ciV22B6mdrTlpYIO6JPvgUIVHOdGdgw9z_SpOlodw830p-M3TUjm_twOg18_eF0SlZONA-jsO2Syf6tkWO0nReNssaZiCyPU/s1600/Cattura.PNG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="646" data-original-width="712" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhEwVALGMpHU8EKrIKYxQmLdmlkEmVITwNHCuxu73sygW8ciV22B6mdrTlpYIO6JPvgUIVHOdGdgw9z_SpOlodw830p-M3TUjm_twOg18_eF0SlZONA-jsO2Syf6tkWO0nReNssaZiCyPU/s1600/Cattura.PNG" /></a></div>
Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-8224116028136258752019-07-07T13:59:00.000-07:002024-01-08T10:53:45.784-08:00Verbale ADA Roma- Associazione Diabetici ODV 2019Roma, 15 maggio 2019<br />
Verbale Assemblea Annuale soci ADA Roma-Associazione diabetici ODV<br />
<br />
Alle ore 15,50 di mercoledì 15 maggio 2019 presso la sala d’attesa del Centro Diabetologico – Presidio Santa Maria, Via S. Giovanni in Laterano n. 155, hanno inizio i lavori dell’Assemblea annuale dell’associazione ADA Roma ODV, regolarmente costituita con il seguente o.d.g.:<br />
<br />
1- Relazione del presidente sull’attività svolta dall’Associazione nell’anno 2018;<br />
2- Adesione della ns. Associazione a Federdiabete Lazio: vantaggi e prospettive;<br />
3- Bilancio: discussione e approvazione;<br />
4- Interventi dei soci: richieste e proposte per migliorare la ns. attività di volontariato;<br />
5- Varie ed eventuali.<br />
<br />
Il presidente Venanzo Paganelli illustra la relazione dell’attività svolta nel 2018: l’adeguamento dello statuto, necessario per ottenere l’iscrizione al registro regionale delle associazioni di volontariato della Regione Lazio. Requisito indispensabile per ricevere il riconoscimento da parte dell’Azienda Ospedaliera S. Giovanni-Addolorata. <br />
<br />
Il nome dell’Associazione è stato così modificato: “ADA Roma- Associazione Diabetici ODV”. L’iter burocratico ha richiesto spese per l’assicurazione obbligatoria per i soci che svolgono la loro attività c/o il Centro: la polizza dovrà essere rinnovata annualmente. Questa procedura ha impegnato tempo e denaro che è stato versato agli uffici esattoriali competenti: l’ADA Roma potrà così accedere, attraverso la dichiarazione del redditi, al contributo del 5x1000 apponendo il ns. CODICE FISCALE e alle donazioni con il codice IBAN. Per diffondere l’informazione sono stati stampati 5000 volantini. Un’altra novità positiva è l’assegnazione di una stanza per l’Associazione condivisa con lo specialista podologo presente in sede il lunedì e giovedì, a seguito di donazione al Centro diabetologico: presenza importante ai fini della prevenzione delle complicanze al piede. Anche l’ADA Roma, per donazione, garantisce la presenza di una psicologa per la valutazione propedeutica all’impianto dei microinfusori. <br />
<br />
L’ADA Roma è stata la prima tra le associazioni presenti nell’Ospedale S.Giovanni a ricevere il riconoscimento dall’Azienda e, insieme alle altre, parteciperà alla Consulta Aziendale con la possibilità di presentare progetti/proposte. <br />
<br />
Paganelli proporrà alla Consulta di istituzionalizzare la presenza del podologo: iniziativa che viene accolta positivamente dai presenti che richiedono di poter essere valutati dallo specialista, seppure le loro visite di controllo non coincidano nei giorni di presenza dello stesso.<br />
<br />
Il presidente informa che il Direttore Sanitario dr. Antonio Fortino ha convocato la ns. e le altre Associazioni per il Regolamento della Consulta e per la Delibera relativa all’Umanizzazione dell’Azienda Ospedaliera: un importante riconoscimento per tutti i volontari. Paganelli espone l’importanza della ns. adesione alla Federdiabete Lazio e legge la lettera della presidente Lina delle Monache, dove si parla dell’accordo-quadro relativo ai glucometri, scelti con criteri di qualità.<br />
<br />
Si dà lettura del bilancio che viene approvato all’unanimità.<br />
<br />
Interviene Francesco D’Aprile che presenta il corso di informatica da lui tenuto e dalla sua Associazione “Informatici senza frontiere”, per coinvolgere i soci nell’uso del PC con altri strumenti: glucometri, holter, sensori ed altri.<br />
Il corso si prefigge di trattare il PC nelle sue componenti e di aiutare i pazienti nella gestione dei dati dei monitoraggi glicemici. Questo contribuirà, in sede di visita di controllo, a diminuire i tempi d’attesa per scaricare i dati. Francesco D’Aprile informa che i corsi verranno replicati e, se richiesti, estesi al personale infermieristico. <br />
<br />
Terminati gli interventi, alle ore 18,00 si conclude l’assemblea.<br />
<br />
Il segretario Il presidente<br />
Maria Nieddu Venanzo Paganelli<br />
<br />
Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-39130550596462403012019-07-01T09:26:00.002-07:002024-01-08T10:54:03.499-08:00Giornata del Volontariato 24 giugno 2019Buongiorno, in riferimento alla Festa del Volontariato, lieto evento celebrato lunedì scorso insieme, alla presenza della Direzione Strategica e della Testimonial S.Sandrelli entusiasta per tale iniziativa, Vi comunico che il Tecnico Aziendale Silvio David , che ringrazio per la Sua tempestività, ha già provveduto a pubblicare sul Canale You Tube Aziendale il video in oggetto. Ritenendo opportuno darne formale notizia ad ogni singola Associazione, lo stesso inoltre comunica che il video potrà essere visionato dal Sito Aziendale cliccando su Galleria/Video o direttamente al seguente <a href="https://www.youtube.com/watch?v=0w1d_H4XpK8" target="_blank">link</a>. Colgo l'occasione per inoltrare un caloroso saluto a tutti ed un ringraziamento speciale per l'impegno dimostrato nella realizzazione dell'Evento e per il prezioso quotidiano contributo. Nel ricordo della bellissima e coinvolgente esperienza, anche canora, dedicata a Voi e anche ai Sanitari, e sperando di continuare insieme per questo umano percorso, Vi auguro una buona giornata. Cordialità Dr.ssa Claudia Marchionni Coordinatore Infermieristico Direzione Assistenza Infermieristica Interim Coord. Inf.co Servizio Picc Team - C.d.C 11030000 tel.int.- 6698 cell 3311706704 fax 79408 Visualizza il seguente <a href="https://www.youtube.com/watch?v=0w1d_H4XpK8" target="_blank">link</a> .Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-1973130734941465972019-01-29T08:25:00.000-08:002024-01-08T10:54:30.634-08:00Lettera a Mario<br />
<div class="gs" style="background-color: white; margin: 0px; padding: 0px 0px 20px; width: 958px;">
<div class="">
<div class="ii gt" id=":o1" style="direction: ltr; margin: 8px 0px 0px; padding: 0px; position: relative;">
<div class="a3s aXjCH " id=":o0" style="font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: 1.5; overflow: hidden;">
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
<br /></div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
<br /></div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
Domenica 20 gennaio 2019 è scomparso il nostro carissimo socio e amico, Mario Arrà.</div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
Tutti coloro che hanno avuto modo di conoscerlo rimpiangono la sua perdita, perchè </div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
Mario è sempre stato una persona che ha dato tanto, e non solo all'Associazione ADARoma</div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
della quale è stato socio fondatore, ma a chiunque avesse avuto l'occasione di parlarci sia pure per</div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
poco. Sempre solare con il suo sorriso che trasmetteva tranquillità e simpatia ,</div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
nei molteplici interlocutori,</div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
Parlava sempre con garbo e gentilezza, pronto a mettersi a disposizione in tutte quelle occasioni che </div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
si sono presentate, per aiutare il prossimo, </div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
Era insito nella sua natura tale comportamento: dove c'era necessità, lui era presente e disponibile.</div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
Forse quest parole non lo rappresentano completamente, ma a quanti di noi hanno avuto modo</div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
di conoscerlo, sono quelle che più gli si addicevano.</div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
Ciao Mario, amico carissimo, sei sempre nel nostro cuore</div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
. </div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
Maria Nieddu e il Consiglio Direttivo</div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
<br /></div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
<br /></div>
<div style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; text-align: left;">
<br /></div>
<div class="yj6qo" style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small;">
</div>
<div class="adL" style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small;">
<br /></div>
</div>
</div>
<div class="hi" style="background: rgb(242, 242, 242); border-bottom-left-radius: 1px; border-bottom-right-radius: 1px; color: #222222; font-family: Roboto, RobotoDraft, Helvetica, Arial, sans-serif; margin: 0px; padding: 0px; width: auto;">
</div>
</div>
</div>
Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-87632714589741284312019-01-13T08:38:00.000-08:002024-01-08T10:54:50.417-08:00Lettera del Presidente Venanzo Paganelli<br />
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjixFwzOF8a8hCJuDxHtKc0S8nWgCeZK5l2JmAPJs5lhs7WCydSFgZcrJbIy3X7MEgQarVsXcQTTlFiKLgk8bqEypxktjAg8UJGAtUKAnNH16BO7xzNBb0GoC1dJj4SnKLPe7adQW6ick4/s1600/allegato_ada.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="640" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjixFwzOF8a8hCJuDxHtKc0S8nWgCeZK5l2JmAPJs5lhs7WCydSFgZcrJbIy3X7MEgQarVsXcQTTlFiKLgk8bqEypxktjAg8UJGAtUKAnNH16BO7xzNBb0GoC1dJj4SnKLPe7adQW6ick4/s640/allegato_ada.png" width="452" /></a></div>
Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0tag:blogger.com,1999:blog-3345719525133043583.post-89892154319461637102018-12-13T00:12:00.002-08:002024-01-08T10:55:06.802-08:00<div data-referrer="pagelet_composer" id="pagelet_composer">
<div>
<div aria-label="Crea un post" class=" _3u13 _3e9r" data-ft="{"tn":"-r"}" id="js_nc" role="region">
<div class="_3u16">
<div>
<div class="_nh6 _3qd3" id="feedx_sprouts_container">
<div class="_4-u2 _1qby _1cx1 focus_target _4a8c _4aay _4ab3 _4-u8" id="rc.u_jsonp_3_3">
<form action="https://www.facebook.com/ajax/updatestatus.php?av=100001929036759&eav=Afa5j7TU_2pKQj82qFp5PkjGDQvL4j13wkg2OwIzrtgCnZXH0CAmpOoyvOieIDhHRxI" class="_559p" id="u_jsonp_3_e" method="post" rel="async">
<div class="_16ve">
<span class="_16vg _1oxv"><div class="_5xmp">
<div class="_m_1" data-hover="tooltip" data-sprout-tagger-id="PEOPLE" id="js_39q" role="tab">
<div class="_2aha" data-tooltip-content="Tagga amici" data-tooltip-delay="500" data-tooltip-display="overflow">
Tagga amici</div>
</div>
</div>
<div class="_5xmp">
<div class="_m_1 _1gr3" data-hover="tooltip" role="tab">
<i class="_4a0a img sp_OGGLuxGda8S_1_5x sx_d677b6"></i><div class="_2aha" data-tooltip-content="" data-tooltip-delay="500" data-tooltip-display="overflow">
</div>
</div>
</div>
</span></div>
</form>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<div data-referrer="pagelet_prompts" id="pagelet_prompts">
</div>
<div data-gt="{"ref":"nf_generic"}" data-referrer="topnews_main_stream_408239535924329" id="topnews_main_stream_408239535924329">
<div aria-label="Notizie" class="_5pcb _dp7 _4j3f" data-testid="newsFeedStream" id="feed_stream_5c12130c2fe757129266688" role="region">
<h2 class="accessible_elem" id="newsFeedHeading">
Notizie</h2>
<div role="feed">
<div class="_4ikz" data-referrer="substream_0" id="substream_0">
<div id="u_ps_jsonp_3_0_0">
<div aria-describedby="js_n6 js_n7" aria-labelledby="js_n5" aria-posinset="1" aria-setsize="19" class="_5jmm _5pat _3lb4 w_y5lgdtmkx" data-cursor="MTU0NDY4ODM5NjoxNTQ0Njg4Mzk2OjE6NDE5NDQ3NDc0NDgzNzk5NTU4MjowOjY2MzQzODYxNDUyMzI3NjAxNDc=" data-dedupekey="4194474744837995582" data-fte="1" data-ftr="1" data-insertion-position="0" data-referrer="hyperfeed_story_id_5c12130cc1c3a3e96510656" data-testid="fbfeed_story" data-timestamp="1544684457" id="hyperfeed_story_id_5c12130cc1c3a3e96510656" role="article">
<div class="_4-u2 mbm _4mrt _5v3q _4-u8" id="u_ps_jsonp_3_0_1">
<div class="_3ccb" data-ft="{"tn":"-R"}" data-gt="{"type":"click2canvas","fbsource":703,"ref":"nf_generic"}" id="u_ps_jsonp_3_0_2">
<div>
</div>
<div>
</div>
<div class="_5pcr userContentWrapper" data-ft="{"tn":"-R"}">
<div class="_1dwg _1w_m _q7o">
<div class="_4r_y" id="u_ps_jsonp_3_0_3">
<div class="_6a uiPopover _5pbi _cmw _b1e _1wbl" data-ft="{"tn":"V"}" id="u_ps_jsonp_3_0_4">
<a aria-expanded="false" aria-haspopup="true" aria-label="Opzioni per la notizia" class="_4xev _p" data-testid="post_chevron_button" href="https://www.facebook.com/#" id="u_ps_jsonp_3_0_6" rel="toggle" role="button"></a></div>
</div>
<div>
<div class="s_y5lgdy5qj g_y5lgdrusi clearfix">
<div class="clearfix n_y5lgdy4ls">
<a aria-hidden="true" class="_5pb8 k_y5lgdrusl _8o _8s lfloat _ohe" data-ft="{"tn":"\u003C"}" data-hovercard-prefer-more-content-show="1" data-hovercard-referer="ARRWtejt8eSFvYhBEBiHaVGtE0GCLw2eFlrTrOmpWbIFvksRRMG1GXh7CQCfn83VQgk" data-hovercard="/ajax/hovercard/page.php?id=449483468883710&extragetparams=%7B%22__tn__%22%3A%22%2Cd%5Cu003C-R-R%22%2C%22eid%22%3A%22ARCDToiw3yJGQTMMxiWxdtax7OU6fQ5g1pYj-nKUmW-D98Lm8AuuZOImAGHaG-wu1Pk4P7ouOdxI5cA5%22%2C%22hc_ref%22%3A%22ARRWtejt8eSFvYhBEBiHaVGtE0GCLw2eFlrTrOmpWbIFvksRRMG1GXh7CQCfn83VQgk%22%7D" href="https://www.facebook.com/enzobonoracontroildiabete/?ref=nf&__tn__=%3C-R&eid=ARCDToiw3yJGQTMMxiWxdtax7OU6fQ5g1pYj-nKUmW-D98Lm8AuuZOImAGHaG-wu1Pk4P7ouOdxI5cA5&hc_ref=ARRWtejt8eSFvYhBEBiHaVGtE0GCLw2eFlrTrOmpWbIFvksRRMG1GXh7CQCfn83VQgk&__xts__%5B0%5D=68.ARCciqrFCVjJWQzyzt5DDO2eisqLomhIeD-pR4lBm4j-U0tfpXhjJ0fqVo2hotEEZ4GAyu9r6SO2E9DbEK-IuYEKolRcamDfaM7--IBSSFCvYJP2rSIfwBFX85VyDW-4vk8qBBfgOelyxQGojH9siVRhQXHRbCd3VJQ930xUY1gy5t8aXXYM_UG9udxwNX8iVVA-QMjxRFIQu4308YG1mDBIMkkqgWbjHlWe50D2neQyP9eKAnNVailcmMdO9fkLQpQ0Dfk2L_IPqFsMe-sj1mOm8F_zU-2gpN0cn8BuheF1CWDO-xs6vUQln7Wt2VIK6xvmjxfXi3dyxY3gpxJ_n4f6uMDFvI8OSqrq1nfs6_43MJncl1zZbw" tabindex="-1" target=""><div class="_38vo">
<img alt="" aria-label="Enzo Bonora contro il Diabete" class="_s0 _4ooo _5xib _5sq7 _44ma _rw img" role="img" src="https://scontent-mxp1-1.xx.fbcdn.net/v/t1.0-1/c0.7.112.112a/p112x112/38482574_449484188883638_836729435364261888_n.jpg?_nc_cat=105&_nc_ht=scontent-mxp1-1.xx&oh=4bc50fbf55691bd51978c1e89ecb318e&oe=5CADEE7D" /></div>
</a><div class="clearfix _42ef">
<div class="rfloat _ohf">
</div>
<div class="w_y5lgdy4lv">
<div class="_6a _5u5j">
<div class="_6a _6b" style="height: 40px;">
</div>
<div class="_6a _5u5j _6b">
<h5 class="_14f3 _14f5 _5pbw _5vra" data-ft="{"tn":"C"}" id="js_n5">
<span class="fwn fcg"><span class="fwb fcg" data-ft="{"tn":"k"}"><a data-hovercard-prefer-more-content-show="1" data-hovercard-referer="ARQCD7Xemcw0R9UVT65NJb9f0RZpfO04YLz4FvjOS6nxDfs60Zb-ZALSlrvSTqoGRAA" data-hovercard="/ajax/hovercard/page.php?id=449483468883710&extragetparams=%7B%22__tn__%22%3A%22%2CdkC-R-R%22%2C%22eid%22%3A%22ARBjauwpZC4rtlGr86VMjrF9ohi978WrcNE4eEBSb7JCJ6NI7sD-SNSrVLoi82K_gLCSjeei20d3hdB0%22%2C%22hc_ref%22%3A%22ARQCD7Xemcw0R9UVT65NJb9f0RZpfO04YLz4FvjOS6nxDfs60Zb-ZALSlrvSTqoGRAA%22%2C%22fref%22%3A%22nf%22%7D" href="https://www.facebook.com/enzobonoracontroildiabete/?__tn__=kC-R&eid=ARBjauwpZC4rtlGr86VMjrF9ohi978WrcNE4eEBSb7JCJ6NI7sD-SNSrVLoi82K_gLCSjeei20d3hdB0&hc_ref=ARQCD7Xemcw0R9UVT65NJb9f0RZpfO04YLz4FvjOS6nxDfs60Zb-ZALSlrvSTqoGRAA&fref=nf&__xts__%5B0%5D=68.ARCciqrFCVjJWQzyzt5DDO2eisqLomhIeD-pR4lBm4j-U0tfpXhjJ0fqVo2hotEEZ4GAyu9r6SO2E9DbEK-IuYEKolRcamDfaM7--IBSSFCvYJP2rSIfwBFX85VyDW-4vk8qBBfgOelyxQGojH9siVRhQXHRbCd3VJQ930xUY1gy5t8aXXYM_UG9udxwNX8iVVA-QMjxRFIQu4308YG1mDBIMkkqgWbjHlWe50D2neQyP9eKAnNVailcmMdO9fkLQpQ0Dfk2L_IPqFsMe-sj1mOm8F_zU-2gpN0cn8BuheF1CWDO-xs6vUQln7Wt2VIK6xvmjxfXi3dyxY3gpxJ_n4f6uMDFvI8OSqrq1nfs6_43MJncl1zZbw">Enzo Bonora contro il Diabete</a></span></span></h5>
<div class="_5pcp _5lel _2jyu _232_" data-testid="story-subtitle" id="feed_subtitle_247;449483468883710;476394409525949;476394409525949;1544684457:4194474744837995582:5:0">
<span class="g_y5lgdwn2u"><span class="fsm fwn fcg"><a ajaxify="/enzobonoracontroildiabete/photos/a.449916182173772/476394252859298/?type=3&size=500%2C336&fbid=476394252859298&source=12&player_origin=unknown&__xts__%5B0%5D=68.ARCciqrFCVjJWQzyzt5DDO2eisqLomhIeD-pR4lBm4j-U0tfpXhjJ0fqVo2hotEEZ4GAyu9r6SO2E9DbEK-IuYEKolRcamDfaM7--IBSSFCvYJP2rSIfwBFX85VyDW-4vk8qBBfgOelyxQGojH9siVRhQXHRbCd3VJQ930xUY1gy5t8aXXYM_UG9udxwNX8iVVA-QMjxRFIQu4308YG1mDBIMkkqgWbjHlWe50D2neQyP9eKAnNVailcmMdO9fkLQpQ0Dfk2L_IPqFsMe-sj1mOm8F_zU-2gpN0cn8BuheF1CWDO-xs6vUQln7Wt2VIK6xvmjxfXi3dyxY3gpxJ_n4f6uMDFvI8OSqrq1nfs6_43MJncl1zZbw&__tn__=-R" class="_5pcq" href="https://www.facebook.com/enzobonoracontroildiabete/photos/a.449916182173772/476394252859298/?type=3&__xts__%5B0%5D=68.ARCciqrFCVjJWQzyzt5DDO2eisqLomhIeD-pR4lBm4j-U0tfpXhjJ0fqVo2hotEEZ4GAyu9r6SO2E9DbEK-IuYEKolRcamDfaM7--IBSSFCvYJP2rSIfwBFX85VyDW-4vk8qBBfgOelyxQGojH9siVRhQXHRbCd3VJQ930xUY1gy5t8aXXYM_UG9udxwNX8iVVA-QMjxRFIQu4308YG1mDBIMkkqgWbjHlWe50D2neQyP9eKAnNVailcmMdO9fkLQpQ0Dfk2L_IPqFsMe-sj1mOm8F_zU-2gpN0cn8BuheF1CWDO-xs6vUQln7Wt2VIK6xvmjxfXi3dyxY3gpxJ_n4f6uMDFvI8OSqrq1nfs6_43MJncl1zZbw&__tn__=-R" rel="theater" target=""><abbr class="_5ptz timestamp livetimestamp" data-shorten="1" data-utime="1544684457" title="13/12/18, 08:00"><span class="timestampContent" id="js_n6">1 h</span></abbr></a></span></span><span aria-hidden="true" class="_6spk" role="presentation"> · </span><a aria-label="Tutti" class="uiStreamPrivacy inlineBlock fbStreamPrivacy fbPrivacyAudienceIndicator _5pcq" data-hover="tooltip" data-tooltip-content="Tutti" href="https://www.facebook.com/#" role="button"><i class="lock img sp__EFZWPnvn_g_1_5x sx_1880b8"></i></a></div>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="_5pbx userContent _3576" data-ad-preview="message" data-ft="{"tn":"K"}" id="js_n7">
<div class="text_exposed_root text_exposed" id="id_5c12130cc85142590540488">
La prevenzione del diabete tipo 2 ovvero 2 forchettate in meno e 4 passi in più. <br />
La crescita enorme dei casi di diabete (quasi mezzo miliardo nel mondo,
circa 4 milioni in Italia) è largamente attribuibile all'esplosione
epidemiologica del diabete tipo 2. L'origine di questa varietà di
diabete (circa il 90% dei casi) è strettamente legata, in persone
predisposte per altri motivi, fra cui quelli genetici, ad uno stile di
vita errato: troppo cibo rispetto all'attività fisica s<span class="text_exposed_show">volta. <br />
La possibilità della prevenzione del diabete tipo 2 è stata dimostrata
con diversi studi basati su interventi che hanno riguardato
alimentazione e attività fisica. La prevenzione con alcuni farmaci è
stata pure osservata ma al momento non è raccomandata. <br /> Da più parti
e in molti Paesi del mondo è stata sottolineata la necessità di
prevenire il diabete tipo 2 e in alcune realtà (pochissime) sono state
avviate campagne di prevenzione, in genere basate su programmi educativi
proposti attraverso i media (stampa, cartelli pubblicitari, radio,
televisione, internet, ecc.). Tutti i programmi di prevenzione sono
incentrati su un modo più salutare di alimentarsi e sui benefici
dell'attività fisica, anche lieve-moderata. <br /> Nel suo piccolo questa
pagina Facebook sta partecipando su base volontaria, indipendente e
senza alcun sostegno economico a divulgare anche concetti che mirano a
prevenire il diabete tipo 2. <br /> Qualsiasi programma di prevenzione,
tuttavia, richiede che il diretto interessato, soprattutto se ad alto
rischio di sviluppare il diabete (circa 1 italiano su 6) agisca
cambiando PER SEMPRE il proprio stile di vita. Il che, molto
semplicemente, potrebbe anche solo consistere nell'applicare
scrupolosamente ogni giorno (o quasi) questa massima: 2 forchettate in
meno, 4 passi in più. Basta poco, ripetuto ogni giorno, per ottenere
benefici notevoli. Quel poco che è alla portata di tutti. <br /> Non è il sistema sanitario nazionale che potrà mai prevenire il diabete tipo 2 ma lo potrà la volontà del singolo individuo. <br /> Il diabete tipo 2 è malattia largamente evitabile. Basta volerlo.</span></div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
Ada Romahttp://www.blogger.com/profile/13921711711955610214noreply@blogger.com0